David C. Madoff, MD

• Andrew Li
• Anne Marie Boustani
• Daniel Coman
• Darryl Zuckerman
• Dhanpat Jain
• Fabian Max Laage Gaupp
• Gavitt Woodard
• Henry S. Park
• James Duncan
• John Onofrey
• Joshua Cornman-Homonoff
• Juan Carlos Perez Lozada
• Julius Chapiro
• Justin D. Blasberg
• Lawrence Staib
• Mario Strazzabosco
• MingDe Lin
• Ramesh Batra
• Todd Schlachter
• Xuchen Zhang

Biliary Tract Neoplasms; Carcinoma, Renal Cell; Carcinoma, Hepatocellular; Hypertension, Portal; Liver Cirrhosis; Liver Cirrhosis, Experimental; Liver Neoplasms; Neoplasm Metastasis; Colorectal Neoplasms; Clinical Trial, Phase I; Cholangiocarcinoma; Neuroendocrine Tumors; Regenerative Medicine; Small Cell Lung Carcinoma

• Bowel injury during percutaneous radiologic gastrostomy tube placement: a case series.Deshmukh A, Ali R, Madoff D, Silin D, Zuckerman D, Cornman-Homonoff J. Bowel injury during percutaneous radiologic gastrostomy tube placement: a case series. Journal Of Vascular And Interventional Radiology 2023 PMID: 37164038, DOI: 10.1016/j.jvir.2023.04.024.
• Emerging Indications for Interventional Oncology: Expert Discussion on New Locoregional TreatmentsIezzi R, Gangi A, Posa A, Pua U, Liang P, Santos E, Kurup A, Tanzilli A, Tenore L, De Leoni D, Filippiadis D, Giuliante F, Valentini V, Gasbarrini A, Goldberg S, Meijerink M, Manfredi R, Kelekis A, Colosimo C, Madoff D. Emerging Indications for Interventional Oncology: Expert Discussion on New Locoregional Treatments. Cancers 2023, 15: 308. PMID: 36612304, PMCID: PMC9818393, DOI: 10.3390/cancers15010308.
• Experimental VX2 Rabbit Liver Tumor Model in Carbon Tetrachloride–Induced Cirrhosis of the LiverSantana J, Shewarega A, Nam D, Kahl V, Madoff D, Zhang X, Chapiro J. Experimental VX2 Rabbit Liver Tumor Model in Carbon Tetrachloride–Induced Cirrhosis of the Liver. Journal Of Vascular And Interventional Radiology 2022, 34: 404-408.e1. PMID: 36473611, DOI: 10.1016/j.jvir.2022.11.026.
• MR Imaging–Based In Vivo Macrophage Imaging to Monitor Immune Response after Radiofrequency Ablation of the LiverSantana J, Petukhova-Greenstein A, Gross M, Hyder F, Pekurovsky V, Gottwald L, Boustani A, Walsh J, Kucukkaya A, Malpani R, Madoff D, Goldberg S, Ahmed M, Joshi N, Coman D, Chapiro J. MR Imaging–Based In Vivo Macrophage Imaging to Monitor Immune Response after Radiofrequency Ablation of the Liver. Journal Of Vascular And Interventional Radiology 2022, 34: 395-403.e5. PMID: 36423815, DOI: 10.1016/j.jvir.2022.11.013.
• Defining textbook outcome for selective internal radiation therapy of hepatocellular carcinoma: an international expert studyGregory J, Tselikas L, Allimant C, de Baere T, Bargellini I, Bell J, Bilbao JI, Bouvier A, Chapiro J, Chiesa C, Decaens T, Denys A, Duran R, Edeline J, Garin E, Ghelfi J, Helmberger T, Irani F, Lam M, Lewandowski R, Liu D, Loffroy R, Madoff DC, Mastier C, Salem R, Sangro B, Sze D, Vilgrain V, Vouche M, Guiu B, Ronot M. Defining textbook outcome for selective internal radiation therapy of hepatocellular carcinoma: an international expert study. European Journal Of Nuclear Medicine And Molecular Imaging 2022, 50: 921-928. PMID: 36282299, DOI: 10.1007/s00259-022-06002-5.
• Locoregional Therapy in the Management of Intrahepatic Cholangiocarcinoma: Is There Sufficient Evidence to Guide Current Clinical Practice?Wang Y, Strazzabosco M, Madoff DC. Locoregional Therapy in the Management of Intrahepatic Cholangiocarcinoma: Is There Sufficient Evidence to Guide Current Clinical Practice? Current Oncology Reports 2022, 24: 1741-1750. PMID: 36255606, DOI: 10.1007/s11912-022-01338-5.
• Long-Term Survival After Surgery Versus Ablation for Early Liver Cancer in a Large, Nationally Representative CohortCharalel RA, Mushlin AI, Li D, Mao J, Ibrahim S, Carlos R, Kwan SW, Fortune B, Talenfeld AD, Brown RS, Madoff DC, Johnson MS, Sedrakyan A. Long-Term Survival After Surgery Versus Ablation for Early Liver Cancer in a Large, Nationally Representative Cohort. Journal Of The American College Of Radiology 2022, 19: 1213-1223. PMID: 36208842, DOI: 10.1016/j.jacr.2022.07.010.
• S2433 A Rare Case of Esophageal Perforation in Liposarcoma After CryoablationSamardzic T, Patel N, Ramras S, Detterbeck F, Madoff D. S2433 A Rare Case of Esophageal Perforation in Liposarcoma After Cryoablation. The American Journal Of Gastroenterology 2022, 117: e1624-e1625. DOI: 10.14309/01.ajg.0000866372.42343.f2.
• Night Watch: Positive Effect of a Night Float Call System on IR Resident WellnessChan SM, Laage Gaupp FM, Green CS, Malpani R, Madoff DC. Night Watch: Positive Effect of a Night Float Call System on IR Resident Wellness. Journal Of Vascular And Interventional Radiology 2022, 33: 1616-1618. PMID: 36049663, DOI: 10.1016/j.jvir.2022.08.025.
• Machine Learning Models for Prediction of Posttreatment Recurrence in Early-Stage Hepatocellular Carcinoma Using Pretreatment Clinical and MRI Features: A Proof-of-Concept Study.Iseke S, Zeevi T, Kucukkaya AS, Raju R, Gross M, Haider SP, Petukhova-Greenstein A, Kuhn TN, Lin M, Nowak M, Cooper K, Thomas E, Weber MA, Madoff DC, Staib L, Batra R, Chapiro J. Machine Learning Models for Prediction of Posttreatment Recurrence in Early-Stage Hepatocellular Carcinoma Using Pretreatment Clinical and MRI Features: A Proof-of-Concept Study. American Journal Of Roentgenology 2022, 220: 245-255. PMID: 35975886, PMCID: PMC10015590, DOI: 10.2214/ajr.22.28077.
• An Expert, Multidisciplinary Perspective on Best Practices in Biomarker Testing in Intrahepatic CholangiocarcinomaMadoff DC, Abi-Jaoudeh N, Braxton D, Goyal L, Jain D, Odisio BC, Salem R, Schattner M, Sheth R, Li D. An Expert, Multidisciplinary Perspective on Best Practices in Biomarker Testing in Intrahepatic Cholangiocarcinoma. The Oncologist 2022, 27: 884-891. PMID: 35925597, PMCID: PMC9526481, DOI: 10.1093/oncolo/oyac139.
• Oncopharmacology in Interventional RadiologyRaja J, Madoff D. Oncopharmacology in Interventional Radiology. Seminars In Interventional Radiology 2022, 39: 411-415. PMID: 36406031, PMCID: PMC9671678, DOI: 10.1055/s-0042-1758076.
• Dragon 1 Protocol Manuscript: Training, Accreditation, Implementation and Safety Evaluation of Portal and Hepatic Vein Embolization (PVE/HVE) to Accelerate Future Liver Remnant (FLR) HypertrophyKorenblik R, Olij B, Aldrighetti LA, Hilal MA, Ahle M, Arslan B, van Baardewijk LJ, Baclija I, Bent C, Bertrand CL, Björnsson B, de Boer MT, de Boer SW, Bokkers RPH, Rinkes IHMB, Breitenstein S, Bruijnen RCG, Bruners P, Büchler MW, Camacho JC, Cappelli A, Carling U, Chan BKY, Chang DH, choi J, Font JC, Crawford M, Croagh D, Cugat E, Davis R, De Boo DW, De Cobelli F, De Wispelaere JF, van Delden OM, Delle M, Detry O, Díaz-Nieto R, Dili A, Erdmann JI, Fisher O, Fondevila C, Fretland Å, Borobia FG, Gelabert A, Gérard L, Giuliante F, Gobardhan PD, Gómez F, Grünberger T, Grünhagen DJ, Guitart J, Hagendoorn J, Heil J, Heise D, Herrero E, Hess GF, Hoffmann MH, Iezzi R, Imani F, Nguyen J, Jovine E, Kalff JC, Kazemier G, Kingham TP, Kleeff J, Kollmar O, Leclercq WKG, Ben SL, Lucidi V, MacDonald A, Madoff DC, Manekeller S, Martel G, Mehrabi A, Mehrzad H, Meijerink MR, Menon K, Metrakos P, Meyer C, Moelker A, Modi S, Montanari N, Navines J, Neumann UP, Peddu P, Primrose JN, Qu X, Raptis D, Ratti F, Ridouani F, Rogan C, Ronellenfitsch U, Ryan S, Sallemi C, Moragues JS, Sandström P, Sarriá L, Schnitzbauer A, Serenari M, Serrablo A, Smits MLJ, Sparrelid E, Spüntrup E, Stavrou GA, Sutcliffe RP, Tancredi I, Tasse JC, Udupa V, Valenti D, Fundora Y, Vogl TJ, Wang X, White SA, Wohlgemuth WA, Yu D, Zijlstra IAJ, Binkert CA, Bemelmans MHA, van der Leij C, Schadde E, van Dam RM. Dragon 1 Protocol Manuscript: Training, Accreditation, Implementation and Safety Evaluation of Portal and Hepatic Vein Embolization (PVE/HVE) to Accelerate Future Liver Remnant (FLR) Hypertrophy. CardioVascular And Interventional Radiology 2022, 45: 1391-1398. PMID: 35790566, PMCID: PMC9458562, DOI: 10.1007/s00270-022-03176-1.
• SAT594 Use of machine learning to predict the histopathological ImmunoScore in hepatocellular carcinoma on multiparametric MRIYang J, Shewarega A, Santana J, Pekurovsky V, Zhang X, Lin M, Madoff D, Staib L, Chapiro J, Duncan J. SAT594 Use of machine learning to predict the histopathological ImmunoScore in hepatocellular carcinoma on multiparametric MRI. Journal Of Hepatology 2022, 77: s935. DOI: 10.1016/s0168-8278(22)02151-1.
• A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation— part 1: a guide to decision-makingDetterbeck FC, Blasberg JD, Woodard GA, Decker RH, Kumbasar U, Park HS, Mase VJ, Bade BC, Li AX, Brandt WS, Madoff DC. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation— part 1: a guide to decision-making. Journal Of Thoracic Disease 2022, 0: 0-0. PMID: 35813719, PMCID: PMC9264102, DOI: 10.21037/jtd-21-1823.
• A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 2: systematic review of evidence regarding resection extent in generally healthy patientsDetterbeck FC, Mase VJ, Li AX, Kumbasar U, Bade BC, Park HS, Decker RH, Madoff DC, Woodard GA, Brandt WS, Blasberg JD. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 2: systematic review of evidence regarding resection extent in generally healthy patients. Journal Of Thoracic Disease 2022, 0: 0-0. PMID: 35813747, PMCID: PMC9264068, DOI: 10.21037/jtd-21-1824.
• A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 3: systematic review of evidence regarding surgery in compromised patients or specific tumorsBade BC, Blasberg JD, Mase VJ, Kumbasar U, Li AX, Park HS, Decker RH, Madoff DC, Brandt WS, Woodard GA, Detterbeck FC. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 3: systematic review of evidence regarding surgery in compromised patients or specific tumors. Journal Of Thoracic Disease 2022, 0: 0-0. PMID: 35813753, PMCID: PMC9264070, DOI: 10.21037/jtd-21-1825.
• A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 4: systematic review of evidence involving SBRT and ablationPark HS, Detterbeck FC, Madoff DC, Bade BC, Kumbasar U, Mase VJ, Li AX, Blasberg JD, Woodard GA, Brandt WS, Decker RH. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 4: systematic review of evidence involving SBRT and ablation. Journal Of Thoracic Disease 2022, 0: 0-0. PMID: 35813762, PMCID: PMC9264060, DOI: 10.21037/jtd-21-1826.
• Abstract No. 58 Combination, single-session selective transarterial embolization and microwave ablation for large renal masses: medium- to long-term follow-upLaRussa S, Berg R, Craig K, Madoff D, McClure T. Abstract No. 58 Combination, single-session selective transarterial embolization and microwave ablation for large renal masses: medium- to long-term follow-up. Journal Of Vascular And Interventional Radiology 2022, 33: s27-s28. DOI: 10.1016/j.jvir.2022.03.139.
• Abstract No. 245 Y-90 radioembolization in the treatment of pancreatic adenocarcinoma with liver metastasesLee K, Malhotra A, May B, Pua B, Madoff D. Abstract No. 245 Y-90 radioembolization in the treatment of pancreatic adenocarcinoma with liver metastases. Journal Of Vascular And Interventional Radiology 2022, 33: s113. DOI: 10.1016/j.jvir.2022.03.326.
• Abstract No. 171 ▪ FEATURED ABSTRACT The effect of anti-MMP-9 as a potential modulator of the post-cryoablation anti-tumor immune response in HCCShewarega A, Santana J, Nam D, Berz A, Kahl V, Wetter A, Madoff D, Chapiro J. Abstract No. 171 ▪ FEATURED ABSTRACT The effect of anti-MMP-9 as a potential modulator of the post-cryoablation anti-tumor immune response in HCC. Journal Of Vascular And Interventional Radiology 2022, 33: s79. DOI: 10.1016/j.jvir.2022.03.252.
• Impact of Chemoembolic Regimen on Immune Cell Recruitment and Immune Checkpoint Marker Expression following Transcatheter Arterial Chemoembolization in a VX2 Rabbit Liver Tumor ModelBerz AM, Santana JG, Iseke S, Gross M, Pekurovsky V, Laage Gaupp F, Savic LJ, Borde T, Gottwald LA, Boustani AM, Gebauer B, Lin M, Zhang X, Schlachter T, Madoff DC, Chapiro J. Impact of Chemoembolic Regimen on Immune Cell Recruitment and Immune Checkpoint Marker Expression following Transcatheter Arterial Chemoembolization in a VX2 Rabbit Liver Tumor Model. Journal Of Vascular And Interventional Radiology 2022, 33: 764-774.e4. PMID: 35346859, PMCID: PMC9344951, DOI: 10.1016/j.jvir.2022.03.026.
• Randomized Phase 3 LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib Plus Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma Not Amenable to Curative TreatmentLlovet JM, Vogel A, Madoff DC, Finn RS, Ogasawara S, Ren Z, Mody K, Li JJ, Siegel AB, Dubrovsky L, Kudo M. Randomized Phase 3 LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib Plus Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma Not Amenable to Curative Treatment. CardioVascular And Interventional Radiology 2022, 45: 405-412. PMID: 35119481, PMCID: PMC8940827, DOI: 10.1007/s00270-021-03031-9.
• LEAP-012 trial in progress: Transarterial chemoembolization (TACE) with or without lenvatinib plus pembrolizumab for intermediate-stage hepatocellular carcinoma (HCC)El-Khoueiry A, Llovet J, Vogel A, Madoff D, Finn R, Ogasawara S, Ren Z, Mody K, Li J, Siegel A, Dubrovsky L, Kudo M. LEAP-012 trial in progress: Transarterial chemoembolization (TACE) with or without lenvatinib plus pembrolizumab for intermediate-stage hepatocellular carcinoma (HCC). Journal Of Clinical Oncology 2022, 40: tps494-tps494. DOI: 10.1200/jco.2022.40.4_suppl.tps494.
• Bronchial artery embolization for hemoptysis in a postpartum patient via cesarean section with COVID-19 while on extracorporeal membrane oxygenationLee M, Cornman-Homonoff J, Madoff DC. Bronchial artery embolization for hemoptysis in a postpartum patient via cesarean section with COVID-19 while on extracorporeal membrane oxygenation. Clinical Imaging 2022, 83: 123-130. PMID: 35033849, PMCID: PMC8743280, DOI: 10.1016/j.clinimag.2021.12.017.
• Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.Motzer RJ, Jonasch E, Agarwal N, Alva A, Baine M, Beckermann K, Carlo MI, Choueiri TK, Costello BA, Derweesh IH, Desai A, Ged Y, George S, Gore JL, Haas N, Hancock SL, Kapur P, Kyriakopoulos C, Lam ET, Lara PN, Lau C, Lewis B, Madoff DC, Manley B, Michaelson MD, Mortazavi A, Nandagopal L, Plimack ER, Ponsky L, Ramalingam S, Shuch B, Smith ZL, Sosman J, Dwyer MA, Gurski LA, Motter A. Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. Journal Of The National Comprehensive Cancer Network 2022, 20: 71-90. PMID: 34991070, PMCID: PMC10191161, DOI: 10.6004/jnccn.2022.0001.
• Quantitative Automated Segmentation of Lipiodol Deposits on Cone-Beam CT Imaging Acquired during Transarterial Chemoembolization for Liver Tumors: A Deep Learning ApproachMalpani R, Petty CW, Yang J, Bhatt N, Zeevi T, Chockalingam V, Raju R, Petukhova-Greenstein A, Santana JG, Schlachter TR, Madoff DC, Chapiro J, Duncan J, Lin M. Quantitative Automated Segmentation of Lipiodol Deposits on Cone-Beam CT Imaging Acquired during Transarterial Chemoembolization for Liver Tumors: A Deep Learning Approach. Journal Of Vascular And Interventional Radiology 2021, 33: 324-332.e2. PMID: 34923098, PMCID: PMC8972393, DOI: 10.1016/j.jvir.2021.12.017.
• Balloon-assisted radioembolization via the proper hepatic artery to treat a left liver hepatocellular carcinoma and portal vein tumor thrombus with an inaccessible left hepatic artery: A case reportMabey JG, Cornman-Homonoff J, Madoff DC. Balloon-assisted radioembolization via the proper hepatic artery to treat a left liver hepatocellular carcinoma and portal vein tumor thrombus with an inaccessible left hepatic artery: A case report. Clinical Imaging 2021, 82: 244-250. PMID: 34920388, DOI: 10.1016/j.clinimag.2021.11.026.
• Consensus Guidelines for the Definition of Time-to-Event End Points in Image-guided Tumor Ablation: Results of the SIO and DATECAN Initiative.Puijk RS, Ahmed M, Adam A, Arai Y, Arellano R, de Baère T, Bale R, Bellera C, Binkert CA, Brace CL, Breen DJ, Brountzos E, Callstrom MR, Carrafiello G, Chapiro J, de Cobelli F, Coupé VMH, Crocetti L, Denys A, Dupuy DE, Erinjeri JP, Filippiadis D, Gangi A, Gervais DA, Gillams AR, Greene T, Guiu B, Helmberger T, Iezzi R, Kang TW, Kelekis A, Kim HS, Kröncke T, Kwan S, Lee MW, Lee FT, Lee EW, Liang P, Lissenberg-Witte BI, Lu DS, Madoff DC, Mauri G, Meloni MF, Morgan R, Nadolski G, Narayanan G, Newton I, Nikolic B, Orsi F, Pereira PL, Pua U, Rhim H, Ricke J, Rilling W, Salem R, Scheffer HJ, Sofocleous CT, Solbiati LA, Solomon SB, Soulen MC, Sze D, Uberoi R, Vogl TJ, Wang DS, Wood BJ, Goldberg SN, Meijerink MR. Consensus Guidelines for the Definition of Time-to-Event End Points in Image-guided Tumor Ablation: Results of the SIO and DATECAN Initiative. Radiology 2021, 301: 533-540. PMID: 34581627, DOI: 10.1148/radiol.2021203715.
• Comparison of metabolic and immunologic responses to transarterial chemoembolization with different chemoembolic regimens in a rabbit VX2 liver tumor modelDoemel LA, Santana JG, Savic LJ, Gaupp FML, Borde T, Petukhova-Greenstein A, Kucukkaya AS, Schobert IT, Hamm CA, Gebauer B, Walsh JJ, Rexha I, Hyder F, Lin M, Madoff DC, Schlachter T, Chapiro J, Coman D. Comparison of metabolic and immunologic responses to transarterial chemoembolization with different chemoembolic regimens in a rabbit VX2 liver tumor model. European Radiology 2021, 32: 2437-2447. PMID: 34718844, PMCID: PMC9359419, DOI: 10.1007/s00330-021-08337-3.
• Systematic Reviews and Meta-Analyses of Portal Vein Embolization, Associated Liver Partition and Portal Vein Ligation, and Radiation Lobectomy Outcomes in Hepatocellular Carcinoma PatientsCharalel RA, Sung J, Askin G, Jo J, Mitry M, Chung C, Tmanova L, Madoff DC. Systematic Reviews and Meta-Analyses of Portal Vein Embolization, Associated Liver Partition and Portal Vein Ligation, and Radiation Lobectomy Outcomes in Hepatocellular Carcinoma Patients. Current Oncology Reports 2021, 23: 135. PMID: 34716800, DOI: 10.1007/s11912-021-01075-1.
• Clinical practice of transarterial chemoembolization for hepatocellular carcinoma: consensus statement from an international expert panel of International Society of Multidisciplinary Interventional Oncology (ISMIO)Lu J, Zhao M, Arai Y, Zhong BY, Zhu HD, Qi XL, de Baere T, Pua U, Yoon HK, Madoff DC, Teng GJ. Clinical practice of transarterial chemoembolization for hepatocellular carcinoma: consensus statement from an international expert panel of International Society of Multidisciplinary Interventional Oncology (ISMIO). HepatoBiliary Surgery And Nutrition 2021, 0: 0-0. PMID: 34760969, PMCID: PMC8527415, DOI: 10.21037/hbsn-21-260.
• Conventional Hepatic Volumetry May Lead to Inaccurate Segmental Yttrium-90 Radiation DosimetryStein SI, Soliman MM, Sparapani J, Doustaly R, Cobb BW, Malhotra A, Charalel R, May BJ, Lee KS, Madoff DC, Talenfeld AD. Conventional Hepatic Volumetry May Lead to Inaccurate Segmental Yttrium-90 Radiation Dosimetry. CardioVascular And Interventional Radiology 2021, 44: 1973-1985. PMID: 34414494, DOI: 10.1007/s00270-021-02898-y.
• Abstract No. 448 Segmental balloon-occluded transarterial chemoembolization of hepatocellular carcinomaMadoff D, Lee K. Abstract No. 448 Segmental balloon-occluded transarterial chemoembolization of hepatocellular carcinoma. Journal Of Vascular And Interventional Radiology 2021, 32: s109-s110. DOI: 10.1016/j.jvir.2021.03.257.
• Abstract No. 37 LEAP-012 trial in progress: pembrolizumab, lenvatinib, and transarterial chemoembolization combination therapy for intermediate-stage hepatocellular carcinoma not amenable to curative treatmentMadoff D, Llovet J, El-Khoueiry A, Kudo M, Finn R, Ogasawara S, Ren Z, Mody K, Li J, Siegel A, Dubrovsky L, Vogel A. Abstract No. 37 LEAP-012 trial in progress: pembrolizumab, lenvatinib, and transarterial chemoembolization combination therapy for intermediate-stage hepatocellular carcinoma not amenable to curative treatment. Journal Of Vascular And Interventional Radiology 2021, 32: s17. DOI: 10.1016/j.jvir.2021.03.453.
• Commentary on: "Rebleeding and Mortality Risk Are Increased by ACLF but Reduced by Pre-emptive TIPS".Cornman-Homonoff J, Madoff D. Commentary on: "Rebleeding and Mortality Risk Are Increased by ACLF but Reduced by Pre-emptive TIPS". American Journal Of Roentgenology 2021, 216: 878. PMID: 33025807, DOI: 10.2214/ajr.20.24811.
• Thermal ablation alone vs thermal ablation combined with transarterial chemoembolization for patients with small (<3 cm) hepatocellular carcinomaChai NX, Chapiro J, Petukhova A, Gross M, Kucukkaya A, Raju R, Zeevi T, Elbanan M, Lin M, Perez-Lozada JC, Schlachter T, Strazzabosco M, Pollak JS, Madoff DC. Thermal ablation alone vs thermal ablation combined with transarterial chemoembolization for patients with small (<3 cm) hepatocellular carcinoma. Clinical Imaging 2021, 76: 123-129. PMID: 33592550, PMCID: PMC8217099, DOI: 10.1016/j.clinimag.2021.01.043.
• Management of Refractory Ascites Due to Portal Hypertension: Current Status.Madoff DC, Cornman-Homonoff J, Fortune BE, Gaba RC, Lipnik AJ, Yarmohammadi H, Ray CE. Management of Refractory Ascites Due to Portal Hypertension: Current Status. Radiology 2021, 298: 493-504. PMID: 33497318, DOI: 10.1148/radiol.2021201960.
• International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheresLevillain H, Bagni O, Deroose CM, Dieudonné A, Gnesin S, Grosser OS, Kappadath SC, Kennedy A, Kokabi N, Liu DM, Madoff DC, Mahvash A, Martinez de la Cuesta A, Ng DCE, Paprottka PM, Pettinato C, Rodríguez-Fraile M, Salem R, Sangro B, Strigari L, Sze DY, de Wit van der veen BJ, Flamen P. International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres. European Journal Of Nuclear Medicine And Molecular Imaging 2021, 48: 1570-1584. PMID: 33433699, PMCID: PMC8113219, DOI: 10.1007/s00259-020-05163-5.
• Injection Simulation Software Identifies Missed Tumor-Supplying Vessel in a Patient with Residual Disease After Transarterial Chemoembolization for Hepatocellular CarcinomaOrtiz AK, Lee KS, Doustaly R, Talenfeld AD, Madoff DC. Injection Simulation Software Identifies Missed Tumor-Supplying Vessel in a Patient with Residual Disease After Transarterial Chemoembolization for Hepatocellular Carcinoma. CardioVascular And Interventional Radiology 2021, 44: 812-814. PMID: 33388872, DOI: 10.1007/s00270-020-02720-1.
• Hepatocellular carcinoma Liver Imaging Reporting and Data Systems treatment response assessment: Lessons learned and future directionsAslam A, Gian R, Kambadakone A, Spieler B, Miller FH, Gabr AM, Charalel RA, Kim CY, Madoff DC, Mendiratta-Lala M. Hepatocellular carcinoma Liver Imaging Reporting and Data Systems treatment response assessment: Lessons learned and future directions. World Journal Of Hepatology 2020, 12: 738-753. PMID: 33200013, PMCID: PMC7643220, DOI: 10.4254/wjh.v12.i10.738.
• NCCN Guidelines Insights: Kidney Cancer, Version 1.2021.Motzer RJ, Jonasch E, Boyle S, Carlo MI, Manley B, Agarwal N, Alva A, Beckermann K, Choueiri TK, Costello BA, Derweesh IH, Desai A, George S, Gore JL, Haas N, Hancock SL, Kyriakopoulos C, Lam ET, Lau C, Lewis B, Madoff DC, McCreery B, Michaelson MD, Mortazavi A, Nandagopal L, Pierorazio PM, Plimack ER, Ponsky L, Ramalingam S, Shuch B, Smith ZL, Somer B, Sosman J, Dwyer MA, Motter AD. NCCN Guidelines Insights: Kidney Cancer, Version 1.2021. Journal Of The National Comprehensive Cancer Network 2020, 18: 1160-1170. PMID: 32886895, PMCID: PMC10191771, DOI: 10.6004/jnccn.2020.0043.
• LEAP-012 trial in progress: Pembrolizumab plus lenvatinib and transarterial chemoembolization (TACE) in patients with intermediate-stage hepatocellular carcinoma (HCC) not amenable to curative treatmentLlovet J, El-Khoueiry A, Vogel A, Madoff D, Finn R, Ogasawara S, Ren Z, Mody K, Li J, Siegel A, Dubrovsky L, Kudo M. LEAP-012 trial in progress: Pembrolizumab plus lenvatinib and transarterial chemoembolization (TACE) in patients with intermediate-stage hepatocellular carcinoma (HCC) not amenable to curative treatment. Annals Of Oncology 2020, 31: s702-s703. DOI: 10.1016/j.annonc.2020.08.1132.
• LBP14 Proof-of-concept use of machine learning to predict tumor recurrence of early-stage hepatocellular carcinoma before therapy using baseline magnetic resonance imagingKücükkaya A, Zeevi T, Raju R, Chai N, Haider S, Elbanan M, Petukhova A, Lin M, Onofrey J, Nowak M, Cooper K, Thomas E, Gebauer B, Madoff D, Staib L, Batra R, Chapiro J. LBP14 Proof-of-concept use of machine learning to predict tumor recurrence of early-stage hepatocellular carcinoma before therapy using baseline magnetic resonance imaging. Journal Of Hepatology 2020, 73: s130-s131. DOI: 10.1016/s0168-8278(20)30775-3.
• Is There a Role for Combination, Single-Session Selective Transarterial Embolization and Microwave Ablation for Large Renal Masses?LaRussa S, Vanden Berg RW, Craig KM, Madoff DC, McClure TD. Is There a Role for Combination, Single-Session Selective Transarterial Embolization and Microwave Ablation for Large Renal Masses? CardioVascular And Interventional Radiology 2020, 43: 1468-1473. PMID: 32613266, DOI: 10.1007/s00270-020-02568-5.
• P-107 LEAP-012: A randomized, double-blind, phase 3 study of pembrolizumab plus lenvatinib in combination with transarterial chemoembolization (TACE) in patients with intermediate-stage hepatocellular carcinoma not amenable to curative treatmentOgasawara S, Llovet J, El-Khoueiry A, Vogel A, Madoff D, Finn R, Ren Z, Modi K, Li J, Siegel A, Dubrovsky L, Kudo M. P-107 LEAP-012: A randomized, double-blind, phase 3 study of pembrolizumab plus lenvatinib in combination with transarterial chemoembolization (TACE) in patients with intermediate-stage hepatocellular carcinoma not amenable to curative treatment. Annals Of Oncology 2020, 31: s124-s125. DOI: 10.1016/j.annonc.2020.04.189.
• Intraprocedural guidance for recanalization of post-thrombotic venous lesions using live overlay of center lines from pre-operative cross-sectional imaging: a preliminary experienceSundararajan SH, Doustaly R, Avignon G, Madoff DC, Winokur RS. Intraprocedural guidance for recanalization of post-thrombotic venous lesions using live overlay of center lines from pre-operative cross-sectional imaging: a preliminary experience. CVIR Endovascular 2020, 3: 32. PMID: 32567037, PMCID: PMC7306479, DOI: 10.1186/s42155-020-00121-6.
• Response Criteria for Intratumoral Immunotherapy in Solid Tumors: itRECISTGoldmacher GV, Khilnani AD, Andtbacka RHI, Luke JJ, Hodi FS, Marabelle A, Harrington K, Perrone A, Tse A, Madoff DC, Schwartz LH. Response Criteria for Intratumoral Immunotherapy in Solid Tumors: itRECIST. Journal Of Clinical Oncology 2020, 38: 2667-2676. PMID: 32552274, PMCID: PMC7402995, DOI: 10.1200/jco.19.02985.
• Embolotherapy for Hepatic Oncology: Current Perspectives and Future DirectionsBajwa R, Madoff DC, Kishore SA. Embolotherapy for Hepatic Oncology: Current Perspectives and Future Directions. Digestive Disease Interventions 2020, 04: 134-147. PMID: 32832829, PMCID: PMC7437993, DOI: 10.1055/s-0040-1712146.
• Response criteria for intratumoral immunotherapy in solid tumors: ItRECIST.Goldmacher G, Khilnani A, Andtbacka R, Luke J, Hodi F, Marabelle A, Harrington K, Perrone A, Tse A, Madoff D, Schwartz L. Response criteria for intratumoral immunotherapy in solid tumors: ItRECIST. Journal Of Clinical Oncology 2020, 38: 3141-3141. DOI: 10.1200/jco.2020.38.15_suppl.3141.
• Improving the Safety of Major Resection for Hepatobiliary Malignancy: Portal Vein Embolization and Recent Innovations in Liver Regeneration StrategiesMadoff DC, Odisio BC, Schadde E, Gaba RC, Bennink RJ, van Gulik TM, Guiu B. Improving the Safety of Major Resection for Hepatobiliary Malignancy: Portal Vein Embolization and Recent Innovations in Liver Regeneration Strategies. Current Oncology Reports 2020, 22: 59. PMID: 32415401, DOI: 10.1007/s11912-020-00922-x.
• Preparing for liver surgery with “Alphabet Soup”: PVE, ALPPS, TAE-PVE, LVD and RLKim D, Cornman-Homonoff J, Madoff DC. Preparing for liver surgery with “Alphabet Soup”: PVE, ALPPS, TAE-PVE, LVD and RL. HepatoBiliary Surgery And Nutrition 2020, 9: 136-151. PMID: 32355673, PMCID: PMC7188547, DOI: 10.21037/hbsn.2019.09.10.
• PD08-05 IS THERE A ROLE FOR COMBINATION, SINGLE-SESSION SELECTIVE TRANSARTERIAL EMBOLIZATION AND MICROWAVE ABLATION FOR LARGE RENAL MASSES?LaRussa* S, Vanden Berg R, Craig K, Madoff D, McClure T. PD08-05 IS THERE A ROLE FOR COMBINATION, SINGLE-SESSION SELECTIVE TRANSARTERIAL EMBOLIZATION AND MICROWAVE ABLATION FOR LARGE RENAL MASSES? Investigative Urology 2020, 203 DOI: 10.1097/ju.0000000000000835.05.
• Embolotherapeutic Strategies for Hepatocellular Carcinoma: 2020 UpdateKishore SA, Bajwa R, Madoff DC. Embolotherapeutic Strategies for Hepatocellular Carcinoma: 2020 Update. Cancers 2020, 12: 791. PMID: 32224882, PMCID: PMC7226474, DOI: 10.3390/cancers12040791.
• Multicenter Study of Metastatic Lung Tumors Targeted by Interventional Cryoablation Evaluation (SOLSTICE)Callstrom MR, Woodrum DA, Nichols FC, Palussiere J, Buy X, Suh RD, Abtin FG, Pua BB, Madoff DC, Bagla SL, Papadouris DC, Fernando HC, Dupuy DE, Healey TT, Moore WH, Bilfinger TV, Solomon SB, Yarmohammadi H, Krebs HJ, Fulp CJ, Hakime A, Tselikas L, de Baere T. Multicenter Study of Metastatic Lung Tumors Targeted by Interventional Cryoablation Evaluation (SOLSTICE). Journal Of Thoracic Oncology 2020, 15: 1200-1209. PMID: 32151777, PMCID: PMC9201766, DOI: 10.1016/j.jtho.2020.02.022.
• Abstract No. 395 Is there a role for combination, single-session selective transarterial embolization and microwave ablation for large renal masses?Larussa S, Craig K, Berg R, Madoff D, McClure T. Abstract No. 395 Is there a role for combination, single-session selective transarterial embolization and microwave ablation for large renal masses? Journal Of Vascular And Interventional Radiology 2020, 31: s177-s178. DOI: 10.1016/j.jvir.2019.12.456.
• 3:00 PM Abstract No. 32 Ablation versus surgical resection for small hepatocellular carcinoma: a risk-adjusted SEER-Medicare analysisCharalel R, Mao J, Li S, Kwan S, Brunner M, Talenfeld A, Madoff D, Abramson E, Fortune B, Ibrahim S, Mushlin A, Sedrakyan A. 3:00 PM Abstract No. 32 Ablation versus surgical resection for small hepatocellular carcinoma: a risk-adjusted SEER-Medicare analysis. Journal Of Vascular And Interventional Radiology 2020, 31: s18-s19. DOI: 10.1016/j.jvir.2019.12.054.
• Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosisKahn S, Julian J, Kearon C, Gu C, Cohen D, Magnuson E, Comerota A, Goldhaber S, Jaff M, Razavi M, Kindzelski A, Schneider J, Kim P, Chaer R, Sista A, McLafferty R, Kaufman J, Wible B, Blinder M, Vedantham S, Sichlau M, Vlahos A, Smith S, Thalheimer Q, Singh N, Harting R, Gocke J, Guth S, Shah N, Brady P, Schatz M, Horrow M, Markazi P, Forouzan L, Matalon T, Hertzog D, Goday S, Kennedy M, Kaplan R, Campbell T, Hartman J, Nahum E, Venkat A, Krishnamurthy V, Rectenwald J, Henke P, Eliason J, Willatt J, Escobar G, Samuels S, Katzen B, Benenati J, Powell A, Pena C, Wallach H, Gandhi R, Schneider J, Kim S, Hashemi F, Boyle J, Patel N, Verta M, Leung D, Garcia M, Blatt P, Khatri J, Epstein D, Ryan R, Sweeny T, Stillabower M, Kimbiris G, Raman T, Sierzenski P, Getto L, Dignazio M, Sierzenski P, Horvath M, Gornik H, Bartholomew J, Shishehbor M, Peacock F, Joseph D, Kim S, Mahlay N, Clair D, Lyden S, Kapoor B, McLennon G, Pierce G, Newman J, Spain J, Gill A, Hamilton A, Rizzo A, Park W, Dietzek A, Galin I, Plummer D, Hsu R, Broderick P, Keller A, Sayeed S, Slater D, Lustberg H, Akus J, Sidman R, Dhami M, Kohanski P, Bulgaru A, Dulala R, Burch J, Kapur D, Yang J, Ranson M, Wladis A, Varnagy D, Mekhail T, Winter R, Perez-Izquierdo M, Motew S, Royd-Kranis R, Workman R, Kribbs S, Hogsette G, Moore P, Thomason B, Means W, Bonsall R, Stewart J, Golwya D, Azene E, Bottner W, Bishop W, Clayton D, Gundersen L, Riherd J, Shakhnovich I, Ziegelbein K, Chang T, Sharma K, Allison S, Banovac F, Cohen E, Furlong B, Kessler C, McCullough M, Spies J, Lin J, Kaatz S, Getzen T, Miller J, Schwartz S, Kabbani L, McVinnie D, Rundback J, Manno J, Schwab R, Cole R, Herman K, Singh D, Barkama R, Patel A, Comerota A, Pigott J, Seiwert A, Whalen R, Russell T, Assi Z, Kazanjian S, Yobbagy J, Kaminski B, Kaufman A, Begeman G, DiSalle R, Thakur S, Kim P, Jacquet M, Dykes T, Gerding J, Baker C, Debiasto M, Mittleider D, Higgins G, Amberson S, Pezzuti R, Gallagher T, Schainfeld R, Wicky S, Kalva S, Walker G, Salazar G, Pomerantz B, Patel V, Kabrhel C, Iqbal S, Gangull S, Oklu R, Brannan S, Misra S, Bjarnason H, Ashrani A, Caccavale M, Fleming C, Friese J, Heit J, Kalra M, Macedo T, McBane R, McKusick M, Stockland A, Woodrum D, Wysokinski W, Verma A, Davis A, Chung J, Nicker D, Anderson B, Stein R, Weiss M, Patel P, Rilling W, Tutton S, Hieb R, Hohenwalter E, Colella M, Gosset J, White S, Lewis B, Brown K, Rossi P, Seabrook G, Guimaraes M, Selby J, McGary W, Hannegan C, Robison J, Brothers T, Elliott B, Garg N, Anderson M, Uflacker R, Schonholz C, Raney L, Greenberg C, Kaufman J, Keller F, Kolbeck K, Landry G, Mitchell E, Barton R, DeLoughery T, Kalbfleisch N, Minjarez R, Lakin P, Liem T, Moneta G, Farsad K, Fleischman R, French L, Marques V, Al−Hassani Y, Sawar A, Taylor F, Patel R, Malhotra R, Kim D, Hashemi F, Boyle J, Patel R, Padnick M, Gurley M, Cucher F, Sterrenberg R, Deepthi G, Cumaranatunge G, Bhatla S, Jacobs D, Dolen E, Gamboa P, Dean L, Davis T, Lippert J, Khanna S, Schirf B, Silber J, Wood D, McGraw J, LaPerna L, Willette P, Murphy T, Cerezo J, Dhangana R, Ahn S, Dubel G, Haas R, Jay B, Prince E, Soares G, Klinger J, Lambiase R, Jay G, Tubbs R, Beland M, Hampson C, O'Hara R, Thompson C, Beland M, Frodsham A, Gardiner F, Jaffan A, Keating L, Zafar A, Alicic R, Raabe R, Brower J, McClellan D, Pellow T, Zylak C, Davis J, Reilly M, Symington K, Seibold C, Nachreiner R, Murray D, Murray S, Saha S, Luna G, Hodgson K, McLafferty R, Hood D, Moore C, Griffen D, Hurst D, Lubbers D, Kim K, Warren B, Engel J, Suresh D, VanderWoude E, Razdan R, Hutchins M, Rounsborg T, Midathada M, Moravec D, Tilford J, Kim D, Beckman J, Razavi M, Openshaw K, Flanigan D, Loh C, Dorne H, Chan M, Thomas J, Psaila J, Ringold M, Fisher J, Lipcomb A, Oskin T, Wible B, Coleman B, Elliott D, Gaddis G, Cochran C, Natarajan K, Bick S, Cooke J, Hedderman A, Greist A, Miller L, Martinez B, Flanders V, Underhill M, Hofmann L, Sze D, Kuo W, Louie J, Hwang G, Hovsepian D, Kothary N, Berube C, Schreiber D, Jeffrey B, Schor J, Deitch J, Singh K, Hahn B, Ardolic B, Gupta S, Bashir R, Rao A, Garg M, Patil P, Zack C, Cohen G, Schmieder F, Lakhter V, Sacks D, Guay R, Scott M, Cunningham K, Sigal A, Cescon T, Leasure N, Dhurairaj T, Muck P, Knochel K, Lohr J, Barreau J, Recht M, Bhaskaran J, Brahmamdam R, Draper D, Mehta A, Maher J, Sharafuddin M, Lentz S, Nugent A, Sharp W, Kresowik T, Nicholson R, Sun S, Youness F, Pascarella L, Ray C, Knuttinen M, Bui J, Gaba R, Dobiesz V, Shamim E, Nimmagadda S, Peace D, Zain A, Palumto A, Haskal Z, Hirshon J, Richard H, Verceles A, Wong-You-Chong J, Othee B, Patel R, Iliescu B, Williams D, Gemmete J, Krishnamurthy V, Cwikiel W, Cho K, Schields J, Vellody R, Novelli P, Dasika N, Wakefield T, Rectenwald J, Henke P, Desmond J, Froehlich J, Khaja M, Hunter D, Golzarian J, Cressman E, Dotta Y, Schmiechen N, Marek J, Garcia D, Tawil I, Langsfeld M, Moll S, Mauro M, Stavas J, Burke C, Dixon R, Yu H, Keagy B, Kim K, Kasthuri R, Key N, Chaer R, Makaroun M, Rhee R, Cho J, Baril D, Marone L, Hseih M, Feterik K, Smith R, Jeyabalan G, Rogers J, Vinik R, Kinikini D, Kraiss L, Mueller M, Pendleton R, Rondina M, Sarfati M, Wanner N, Johnson S, Hopkins C, Ihnat D, Angle J, Matsumoto A, Harthun N, Turba U, Saad W, Uthlaut B, Nannapaneni S, Ling D, Sabri S, Kern J, Macik B, Hoke G, Park A, Stone J, Sneed B, Syverud S, Davidson K, Sharma A, Haskal Z, Wilkins L, Black C, Asay M, Hatch D, Smilanich R, Patten C, Brown S, Nielsen R, Alward W, Collins J, Nokes M, Geary R, Edwards M, Godshall C, Levy P, Winokur R, Sista A, Madoff D, Lee K, Pua B, DeSancho M, Milizia R, Gao J, Goday S, Kennedy M, Kaplan R, Campbell T, McLean G, Hartman J, Nahum E, Khalid S, Vedantham S, Lewis L, Saad N, Thoelke M, Pallow R, Klein S, Sicard G, Cohen D, Comerota A, Gornik H, Jaff M, Julian J, Kahn S, Kearon C, Kee S, Kindzelski A, Lewis L, Magnuson E, Razavi M, Murphy T, Vedantham S. Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis. Journal Of Vascular Surgery Venous And Lymphatic Disorders 2020, 8: 8-23.e18. PMID: 31843251, PMCID: PMC7681916, DOI: 10.1016/j.jvsv.2019.03.023.
• Applications of transcatheter embolotherapy in preparation for liver transplantation and resectionLin EY, Cornman-Homonoff J, Odisio BC, Madoff DC. Applications of transcatheter embolotherapy in preparation for liver transplantation and resection. Chinese Clinical Oncology 2019, 8: 59. PMID: 31865716, DOI: 10.21037/cco.2019.12.03.
• Interventional oncology: aiming globally to be the 4 th pillar of cancer careMadoff DC, Chapiro J, Pua U. Interventional oncology: aiming globally to be the 4 th pillar of cancer care. Chinese Clinical Oncology 2019, 8: 56. PMID: 31968980, DOI: 10.21037/cco.2019.12.12.
• Transhepatic portal stent placement and jejunal varix embolization for management of treatment-limiting gastrointestinal bleeding in a patient with unresectable recurrent intrahepatic cholangiocarcinomaCornman-Homonoff J, Bassik N, Madoff DC. Transhepatic portal stent placement and jejunal varix embolization for management of treatment-limiting gastrointestinal bleeding in a patient with unresectable recurrent intrahepatic cholangiocarcinoma. Clinical Imaging 2019, 59: 188-191. PMID: 31837541, DOI: 10.1016/j.clinimag.2019.09.012.
• Management of patients with hepatocellular carcinoma and portal vein tumour thrombosis: comparing east and westLu J, Zhang XP, Zhong BY, Lau WY, Madoff DC, Davidson JC, Qi X, Cheng SQ, Teng GJ. Management of patients with hepatocellular carcinoma and portal vein tumour thrombosis: comparing east and west. The Lancet Gastroenterology & Hepatology 2019, 4: 721-730. PMID: 31387735, DOI: 10.1016/s2468-1253(19)30178-5.
• Use of Virtual Injection Software to Aid in Microcatheter Positioning during Transarterial ChemoembolizationSoliman MM, Stein SI, Doustaly R, Madoff DC. Use of Virtual Injection Software to Aid in Microcatheter Positioning during Transarterial Chemoembolization. Journal Of Vascular And Interventional Radiology 2019, 30: 1646-1648. PMID: 31471197, DOI: 10.1016/j.jvir.2019.07.003.
• Interventional radiology's role in the diagnosis and management of patients with gallbladder carcinoma.Fine GC, Smith TA, Stein SI, Madoff DC. Interventional radiology's role in the diagnosis and management of patients with gallbladder carcinoma. Chinese Clinical Oncology 2019, 8: 40. PMID: 31431037, DOI: 10.21037/cco.2019.07.09.
• Management of Advanced Stage Hepatocellular Carcinoma with Extensive Portal Vein Tumor Thrombus Using an Adjustable Dual Balloon Occlusion TechniqueMadoff DC, Kim D, Holzwanger DJ, Kishore SA, Friedman T. Management of Advanced Stage Hepatocellular Carcinoma with Extensive Portal Vein Tumor Thrombus Using an Adjustable Dual Balloon Occlusion Technique. Journal Of Vascular And Interventional Radiology 2019, 30: 1145-1147. PMID: 31133450, DOI: 10.1016/j.jvir.2019.01.006.
• Balloon-Assisted Transarterial Chemoembolization Segmentectomy: An Alternative Strategy in the Treatment of Hypovascular Oligometastatic Liver MetastasesStein SI, Madoff DC. Balloon-Assisted Transarterial Chemoembolization Segmentectomy: An Alternative Strategy in the Treatment of Hypovascular Oligometastatic Liver Metastases. Journal Of Vascular And Interventional Radiology 2019, 30: 1143-1145. PMID: 31126788, DOI: 10.1016/j.jvir.2018.12.704.
• Balloon-Assisted Blood Pressure Reduction in the Downstream Vascular Compartment to Avoid Nontarget Embolization during Transarterial Chemoembolization from the Inferior Phrenic ArteryStein SI, Madoff DC. Balloon-Assisted Blood Pressure Reduction in the Downstream Vascular Compartment to Avoid Nontarget Embolization during Transarterial Chemoembolization from the Inferior Phrenic Artery. Journal Of Vascular And Interventional Radiology 2019, 30: 1642-1644. PMID: 31101418, DOI: 10.1016/j.jvir.2018.12.010.
• Extrahepatic Clinical Application of Vessel Tracking Software and 3D Roadmapping Tools: Preliminary ExperienceSundararajan SH, McClure TD, Winokur RS, Kishore SA, Madoff DC. Extrahepatic Clinical Application of Vessel Tracking Software and 3D Roadmapping Tools: Preliminary Experience. Journal Of Vascular And Interventional Radiology 2019, 30: 1021-1026. PMID: 31003843, DOI: 10.1016/j.jvir.2018.11.039.
• Direct Percutaneous Access and Coil Embolization for Management of Recurrent Jejunal Variceal Hemorrhage in the Setting of a Pre-Existing TIPSCornman-Homonoff J, Madoff DC. Direct Percutaneous Access and Coil Embolization for Management of Recurrent Jejunal Variceal Hemorrhage in the Setting of a Pre-Existing TIPS. Journal Of Vascular And Interventional Radiology 2018, 29: 1626-1629. PMID: 30368320, DOI: 10.1016/j.jvir.2018.05.007.
• Role of interventional radiology in the management of hepatocellular carcinoma: current status.Holzwanger DJ, Madoff DC. Role of interventional radiology in the management of hepatocellular carcinoma: current status. Chinese Clinical Oncology 2018, 7: 49. PMID: 30180753, DOI: 10.21037/cco.2018.07.04.
• Percutaneous Cryoablation for the Management of Chronic Pain Secondary to Locally Recurrent Rectal Cancer with Bowel and Nerve Root InvolvementCornman-Homonoff J, Formenti SC, Chachoua A, Madoff DC. Percutaneous Cryoablation for the Management of Chronic Pain Secondary to Locally Recurrent Rectal Cancer with Bowel and Nerve Root Involvement. Journal Of Vascular And Interventional Radiology 2018, 29: 1296-1298. PMID: 30146202, DOI: 10.1016/j.jvir.2018.02.022.
• Treatment of Hepatic Tumors with Inaccessible Vasculature Using an Adjustable Length Dual Occlusion Balloon Catheter SystemMadoff DC, Holzwanger DJ, Kishore SA, Friedman T. Treatment of Hepatic Tumors with Inaccessible Vasculature Using an Adjustable Length Dual Occlusion Balloon Catheter System. Journal Of Vascular And Interventional Radiology 2018, 29: 1300-1302. PMID: 30146204, DOI: 10.1016/j.jvir.2018.02.005.
• Image-guided Biopsy of Mesenteric, Omental, and Peritoneal DiseaseCornman-Homonoff J, Madoff D. Image-guided Biopsy of Mesenteric, Omental, and Peritoneal Disease. Digestive Disease Interventions 2018, 02: 106-115. DOI: 10.1055/s-0038-1660499.
• Abstract No. 644 Venous intervention guidance with overlay of 3D vessel center lines from preoperative CT/MR imagingSundararajan S, Avignon G, Madoff D, Browne W, Winokur R. Abstract No. 644 Venous intervention guidance with overlay of 3D vessel center lines from preoperative CT/MR imaging. Journal Of Vascular And Interventional Radiology 2018, 29: s267. DOI: 10.1016/j.jvir.2018.01.689.
• Incorporating Quality of Life Metrics in Interventional Oncology PracticeLi D, Madoff DC. Incorporating Quality of Life Metrics in Interventional Oncology Practice. Seminars In Interventional Radiology 2017, 34: 313-321. PMID: 29249854, PMCID: PMC5730443, DOI: 10.1055/s-0037-1608826.
• Celiac Plexus Block and Neurolysis in the Management of Chronic Upper Abdominal PainCornman-Homonoff J, Holzwanger DJ, Lee KS, Madoff DC, Li D. Celiac Plexus Block and Neurolysis in the Management of Chronic Upper Abdominal Pain. Seminars In Interventional Radiology 2017, 34: 376-386. PMID: 29249862, PMCID: PMC5730442, DOI: 10.1055/s-0037-1608861.
• Periprocedural Bleeding Risk Assessment in Chronic Liver DiseaseMay B, Fortune B, Madoff D. Periprocedural Bleeding Risk Assessment in Chronic Liver Disease. Digestive Disease Interventions 2017, 01: 306-312. DOI: 10.1055/s-0038-1629916.
• Radioembolization in Colorectal Metastases: A ReviewAbdelsalam M, Mahvash A, Madoff D, Odisio B, Kuban J, Avritscher R, Murthy R. Radioembolization in Colorectal Metastases: A Review. Digestive Disease Interventions 2017, 01: 208-217. DOI: 10.1055/s-0037-1607965.
• Multicenter Trial of the VenaTech Convertible Vena Cava FilterHohenwalter EJ, Stone JR, O’Moore P, Smith SJ, Selby JB, Lewandowski RJ, Samuels S, Kiproff PM, Trost DW, Madoff DC, Handel J, Gandras EJ, Vlahos A, Rilling WS. Multicenter Trial of the VenaTech Convertible Vena Cava Filter. Journal Of Vascular And Interventional Radiology 2017, 28: 1353-1362. PMID: 28821379, DOI: 10.1016/j.jvir.2017.06.032.
• Portal Vein Embolization in the Treatment of Metastatic Colorectal Cancer: Optimal Approach and Current ControversiesGans D, Siegel C, Patel I, Tavri S, Madoff D, Sutter C. Portal Vein Embolization in the Treatment of Metastatic Colorectal Cancer: Optimal Approach and Current Controversies. Digestive Disease Interventions 2017, 01: 171-183. DOI: 10.1055/s-0037-1606204.
• Stratification, Imaging, and Management of Acute Massive and Submassive Pulmonary EmbolismSista AK, Kuo WT, Schiebler M, Madoff DC. Stratification, Imaging, and Management of Acute Massive and Submassive Pulmonary Embolism. Radiology 2017, 284: 5-24. PMID: 28628412, DOI: 10.1148/radiol.2017151978.
• Balloon-Assisted Transarterial Chemoembolization: A Nascent Strategy for the Treatment of Hepatocellular CarcinomaKishore S, Cheng W, Smirniotopoulos J, Madoff D. Balloon-Assisted Transarterial Chemoembolization: A Nascent Strategy for the Treatment of Hepatocellular Carcinoma. Digestive Disease Interventions 2017, 01: 115-120. DOI: 10.1055/s-0037-1603961.
• Catheter-directed Intraportal Delivery of Endothelial Cell Therapy for Liver Regeneration: A Feasibility Study in a Large-Animal Model of Cirrhosis.Lee KS, Santagostino SF, Li D, Ramjit A, Serrano K, Ginsberg MD, Ding BS, Rafii S, Madoff DC. Catheter-directed Intraportal Delivery of Endothelial Cell Therapy for Liver Regeneration: A Feasibility Study in a Large-Animal Model of Cirrhosis. Radiology 2017, 285: 114-123. PMID: 28498793, DOI: 10.1148/radiol.2017162617.
• Update on Embolization Therapies for Hepatocellular CarcinomaKishore S, Friedman T, Madoff DC. Update on Embolization Therapies for Hepatocellular Carcinoma. Current Oncology Reports 2017, 19: 40. PMID: 28421483, DOI: 10.1007/s11912-017-0597-2.
• Beginnings: Establishing a New Journal for Digestive Disease ManagementKapoor B, Madoff D. Beginnings: Establishing a New Journal for Digestive Disease Management. Digestive Disease Interventions 2017, 01: 001-001. DOI: 10.1055/s-0037-1600137.
• Embolization of Inaccessible and Hypovascular Liver Tumors Using Novel Balloon Occlusion Catheter TechniquesHolzwanger D, Madoff D. Embolization of Inaccessible and Hypovascular Liver Tumors Using Novel Balloon Occlusion Catheter Techniques. Digestive Disease Interventions 2017, 01: s111-s142. DOI: 10.1055/s-0037-1603711.
• Chapter 108C Preoperative portal vein embolization Technique and resultsShindoh J, Madoff D, Aloia T, Vauthey J. Chapter 108C Preoperative portal vein embolization Technique and results. 2017, 1653-1663.e2. DOI: 10.1016/b978-0-323-34062-5.00133-3.
• Preoperative portal vein embolizationLi D, Madoff D. Preoperative portal vein embolization. 2016, 176-192. DOI: 10.1017/cbo9781107338555.020.
• Clinical implications for imaging of vascular invasion in hepatocellular carcinomaBaheti AD, Dunham GM, Ingraham CR, Moshiri M, Lall C, Park JO, Li D, Katz DS, Madoff DC, Bhargava P. Clinical implications for imaging of vascular invasion in hepatocellular carcinoma. Abdominal Radiology 2016, 41: 1800-1810. PMID: 27142384, DOI: 10.1007/s00261-016-0763-2.
• Controversies of preoperative portal vein embolizationMay BJ, Madoff DC. Controversies of preoperative portal vein embolization. Hepatic Oncology 2016, 3: 155-166. PMID: 30191035, PMCID: PMC6095422, DOI: 10.2217/hep-2015-0004.
• 3:46 PMAbstract No. 193 Delayed pneumothorax after percutaneous lung biopsy in the state of CaliforniaPua B, Tang E, Bhat A, Zabih R, Winokur R, Madoff D. 3:46 PMAbstract No. 193 Delayed pneumothorax after percutaneous lung biopsy in the state of California. Journal Of Vascular And Interventional Radiology 2016, 27: s90. DOI: 10.1016/j.jvir.2015.12.238.
• Portal Venous Interventions: State of the ArtMadoff DC, Gaba RC, Weber CN, Clark TW, Saad WE. Portal Venous Interventions: State of the Art. Radiology 2016, 278: 333-353. PMID: 26789601, DOI: 10.1148/radiol.2015141858.
• The role of interventional oncology in the palliative care of cancer patientsLi D, Hussaini S, Kang J, Madoff D. The role of interventional oncology in the palliative care of cancer patients. Expert Review Of Quality Of Life In Cancer Care 2016, 1: 73-87. DOI: 10.1080/23809000.2016.1142358.
• Endovascular Interventions for Acute and Chronic Lower Extremity Deep Venous Disease: State of the ArtSista AK, Vedantham S, Kaufman JA, Madoff DC. Endovascular Interventions for Acute and Chronic Lower Extremity Deep Venous Disease: State of the Art. Radiology 2015, 276: 31-53. PMID: 26101920, PMCID: PMC4787709, DOI: 10.1148/radiol.2015132603.
• 10:10 AM Abstract No. 2 Muliticenter trial of the VenaTech convertible filter: a novel approach to IVC filtrationHohenwalter E, Stone J, O’Moore P, Smith S, Selby J, Lewandowski R, Samuels S, Kiproff P, Trost D, Handel J, Gandras E, Madoff D, Vlahos A, Rilling W. 10:10 AM Abstract No. 2 Muliticenter trial of the VenaTech convertible filter: a novel approach to IVC filtration. Journal Of Vascular And Interventional Radiology 2015, 26: s5-s6. DOI: 10.1016/j.jvir.2014.12.028.
• Characterization of In Vivo Ablation Zones Following Percutaneous Microwave Ablation of the Liver with Two Commercially Available Devices: Are Manufacturer Published Reference Values Useful?Winokur RS, Du JY, Pua BB, Talenfeld AD, Sista AK, Schiffman MA, Trost DW, Madoff DC. Characterization of In Vivo Ablation Zones Following Percutaneous Microwave Ablation of the Liver with Two Commercially Available Devices: Are Manufacturer Published Reference Values Useful? Journal Of Vascular And Interventional Radiology 2014, 25: 1939-1946.e1. PMID: 25307296, DOI: 10.1016/j.jvir.2014.08.014.
• Case 12Covey A, Pua B, Aguado A, Madoff D. Case 12. 2014, 34-36. DOI: 10.1093/med/9780199331277.003.0012.
• Case 13Covey A, Pua B, Aguado A, Madoff D. Case 13. 2014, 37-39. DOI: 10.1093/med/9780199331277.003.0013.
• Case 14Covey A, Pua B, Aguado A, Madoff D. Case 14. 2014, 40-42. DOI: 10.1093/med/9780199331277.003.0014.
• Case 15Covey A, Pua B, Aguado A, Madoff D. Case 15. 2014, 43-45. DOI: 10.1093/med/9780199331277.003.0015.
• Case 16Covey A, Pua B, Aguado A, Madoff D. Case 16. 2014, 46-48. DOI: 10.1093/med/9780199331277.003.0016.
• Case 17Covey A, Pua B, Aguado A, Madoff D. Case 17. 2014, 49-51. DOI: 10.1093/med/9780199331277.003.0017.
• Case 18Covey A, Pua B, Aguado A, Madoff D. Case 18. 2014, 52-54. DOI: 10.1093/med/9780199331277.003.0018.
• Case 19Covey A, Pua B, Aguado A, Madoff D. Case 19. 2014, 55-56. DOI: 10.1093/med/9780199331277.003.0019.
• Case 20Covey A, Pua B, Aguado A, Madoff D. Case 20. 2014, 57-59. DOI: 10.1093/med/9780199331277.003.0020.
• Case 21Covey A, Pua B, Aguado A, Madoff D. Case 21. 2014, 60-62. DOI: 10.1093/med/9780199331277.003.0021.
• Case 22Covey A, Pua B, Aguado A, Madoff D. Case 22. 2014, 63-65. DOI: 10.1093/med/9780199331277.003.0022.
• Case 23Covey A, Pua B, Aguado A, Madoff D. Case 23. 2014, 66-68. DOI: 10.1093/med/9780199331277.003.0023.
• Case 24Covey A, Pua B, Aguado A, Madoff D. Case 24. 2014, 69-71. DOI: 10.1093/med/9780199331277.003.0024.
• Case 11Covey A, Pua B, Aguado A, Madoff D. Case 11. 2014, 31-33. DOI: 10.1093/med/9780199331277.003.0011.
• Case 1Covey A, Pua B, Aguado A, Madoff D. Case 1. 2014, 1-3. DOI: 10.1093/med/9780199331277.003.0001.
• Case 2Covey A, Pua B, Aguado A, Madoff D. Case 2. 2014, 4-6. DOI: 10.1093/med/9780199331277.003.0002.
• Case 3Covey A, Pua B, Aguado A, Madoff D. Case 3. 2014, 7-9. DOI: 10.1093/med/9780199331277.003.0003.
• Case 4Covey A, Pua B, Aguado A, Madoff D. Case 4. 2014, 10-12. DOI: 10.1093/med/9780199331277.003.0004.
• Case 5Covey A, Pua B, Aguado A, Madoff D. Case 5. 2014, 13-15. DOI: 10.1093/med/9780199331277.003.0005.
• Case 6Covey A, Pua B, Aguado A, Madoff D. Case 6. 2014, 16-18. DOI: 10.1093/med/9780199331277.003.0006.
• Case 7Covey A, Pua B, Aguado A, Madoff D. Case 7. 2014, 19-21. DOI: 10.1093/med/9780199331277.003.0007.
• Case 8Covey A, Pua B, Aguado A, Madoff D. Case 8. 2014, 22-24. DOI: 10.1093/med/9780199331277.003.0008.
• Case 9Covey A, Pua B, Aguado A, Madoff D. Case 9. 2014, 25-27. DOI: 10.1093/med/9780199331277.003.0009.
• Case 10Covey A, Pua B, Aguado A, Madoff D. Case 10. 2014, 28-30. DOI: 10.1093/med/9780199331277.003.0010.
• Case 25Covey A, Pua B, Aguado A, Madoff D. Case 25. 2014, 72-74. DOI: 10.1093/med/9780199331277.003.0025.
• Case 26Covey A, Pua B, Aguado A, Madoff D. Case 26. 2014, 75-77. DOI: 10.1093/med/9780199331277.003.0026.
• Case 27Covey A, Pua B, Aguado A, Madoff D. Case 27. 2014, 78-80. DOI: 10.1093/med/9780199331277.003.0027.
• Case 28Covey A, Pua B, Aguado A, Madoff D. Case 28. 2014, 81-83. DOI: 10.1093/med/9780199331277.003.0028.
• Case 29Covey A, Pua B, Aguado A, Madoff D. Case 29. 2014, 84-86. DOI: 10.1093/med/9780199331277.003.0029.
• Case 30Covey A, Pua B, Aguado A, Madoff D. Case 30. 2014, 87-89. DOI: 10.1093/med/9780199331277.003.0030.
• Case 31Covey A, Pua B, Aguado A, Madoff D. Case 31. 2014, 90-92. DOI: 10.1093/med/9780199331277.003.0031.
• Case 32Covey A, Pua B, Aguado A, Madoff D. Case 32. 2014, 93-95. DOI: 10.1093/med/9780199331277.003.0032.
• Case 33Covey A, Pua B, Aguado A, Madoff D. Case 33. 2014, 96-98. DOI: 10.1093/med/9780199331277.003.0033.
• Case 34Covey A, Pua B, Aguado A, Madoff D. Case 34. 2014, 99-101. DOI: 10.1093/med/9780199331277.003.0034.
• Case 35Covey A, Pua B, Aguado A, Madoff D. Case 35. 2014, 102-104. DOI: 10.1093/med/9780199331277.003.0035.
• Case 36Covey A, Pua B, Aguado A, Madoff D. Case 36. 2014, 105-107. DOI: 10.1093/med/9780199331277.003.0036.
• Case 37Covey A, Pua B, Aguado A, Madoff D. Case 37. 2014, 108-110. DOI: 10.1093/med/9780199331277.003.0037.
• Case 38Covey A, Pua B, Aguado A, Madoff D. Case 38. 2014, 111-113. DOI: 10.1093/med/9780199331277.003.0038.
• Case 39Covey A, Pua B, Aguado A, Madoff D. Case 39. 2014, 114-116. DOI: 10.1093/med/9780199331277.003.0039.
• Case 40Covey A, Pua B, Aguado A, Madoff D. Case 40. 2014, 117-119. DOI: 10.1093/med/9780199331277.003.0040.
• Case 41Covey A, Pua B, Aguado A, Madoff D. Case 41. 2014, 120-122. DOI: 10.1093/med/9780199331277.003.0041.
• Case 42Covey A, Pua B, Aguado A, Madoff D. Case 42. 2014, 123-125. DOI: 10.1093/med/9780199331277.003.0042.
• Case 43Covey A, Pua B, Aguado A, Madoff D. Case 43. 2014, 126-128. DOI: 10.1093/med/9780199331277.003.0043.
• Case 44Covey A, Pua B, Aguado A, Madoff D. Case 44. 2014, 129-131. DOI: 10.1093/med/9780199331277.003.0044.
• Case 45Covey A, Pua B, Aguado A, Madoff D. Case 45. 2014, 132-134. DOI: 10.1093/med/9780199331277.003.0045.
• Case 46Covey A, Pua B, Aguado A, Madoff D. Case 46. 2014, 135-137. DOI: 10.1093/med/9780199331277.003.0046.
• Case 47Covey A, Pua B, Aguado A, Madoff D. Case 47. 2014, 138-140. DOI: 10.1093/med/9780199331277.003.0047.
• Case 48Covey A, Pua B, Aguado A, Madoff D. Case 48. 2014, 141-143. DOI: 10.1093/med/9780199331277.003.0048.
• Case 49Covey A, Pua B, Aguado A, Madoff D. Case 49. 2014, 144-146. DOI: 10.1093/med/9780199331277.003.0049.
• Case 50Covey A, Pua B, Aguado A, Madoff D. Case 50. 2014, 147-149. DOI: 10.1093/med/9780199331277.003.0050.
• Case 51Covey A, Pua B, Aguado A, Madoff D. Case 51. 2014, 150-152. DOI: 10.1093/med/9780199331277.003.0051.
• Case 52Covey A, Pua B, Aguado A, Madoff D. Case 52. 2014, 153-155. DOI: 10.1093/med/9780199331277.003.0052.
• Case 53Covey A, Pua B, Aguado A, Madoff D. Case 53. 2014, 156-158. DOI: 10.1093/med/9780199331277.003.0053.
• Case 54Covey A, Pua B, Aguado A, Madoff D. Case 54. 2014, 159-161. DOI: 10.1093/med/9780199331277.003.0054.
• Case 55Covey A, Pua B, Aguado A, Madoff D. Case 55. 2014, 162-164. DOI: 10.1093/med/9780199331277.003.0055.
• Case 56Covey A, Pua B, Aguado A, Madoff D. Case 56. 2014, 165-167. DOI: 10.1093/med/9780199331277.003.0056.
• Case 57Covey A, Pua B, Aguado A, Madoff D. Case 57. 2014, 168-170. DOI: 10.1093/med/9780199331277.003.0057.
• Case 58Covey A, Pua B, Aguado A, Madoff D. Case 58. 2014, 171-173. DOI: 10.1093/med/9780199331277.003.0058.
• Case 59Covey A, Pua B, Aguado A, Madoff D. Case 59. 2014, 174-175. DOI: 10.1093/med/9780199331277.003.0059.
• Case 60Covey A, Pua B, Aguado A, Madoff D. Case 60. 2014, 176-178. DOI: 10.1093/med/9780199331277.003.0060.
• Case 61Covey A, Pua B, Aguado A, Madoff D. Case 61. 2014, 179-181. DOI: 10.1093/med/9780199331277.003.0061.
• Case 62Covey A, Pua B, Aguado A, Madoff D. Case 62. 2014, 182-184. DOI: 10.1093/med/9780199331277.003.0062.
• Case 63Covey A, Pua B, Aguado A, Madoff D. Case 63. 2014, 185-187. DOI: 10.1093/med/9780199331277.003.0063.
• Case 64Covey A, Pua B, Aguado A, Madoff D. Case 64. 2014, 188-190. DOI: 10.1093/med/9780199331277.003.0064.
• Case 65Covey A, Pua B, Aguado A, Madoff D. Case 65. 2014, 191-193. DOI: 10.1093/med/9780199331277.003.0065.
• Case 66Covey A, Pua B, Aguado A, Madoff D. Case 66. 2014, 194-196. DOI: 10.1093/med/9780199331277.003.0066.
• Case 67Covey A, Pua B, Aguado A, Madoff D. Case 67. 2014, 197-199. DOI: 10.1093/med/9780199331277.003.0067.
• Case 68Covey A, Pua B, Aguado A, Madoff D. Case 68. 2014, 200-202. DOI: 10.1093/med/9780199331277.003.0068.
• Case 69Covey A, Pua B, Aguado A, Madoff D. Case 69. 2014, 203-205. DOI: 10.1093/med/9780199331277.003.0069.
• Case 70Covey A, Pua B, Aguado A, Madoff D. Case 70. 2014, 206-208. DOI: 10.1093/med/9780199331277.003.0070.
• Case 71Covey A, Pua B, Aguado A, Madoff D. Case 71. 2014, 209-211. DOI: 10.1093/med/9780199331277.003.0071.
• Case 72Covey A, Pua B, Aguado A, Madoff D. Case 72. 2014, 212-217. DOI: 10.1093/med/9780199331277.003.0072.
• Case 73Covey A, Pua B, Aguado A, Madoff D. Case 73. 2014, 218-223. DOI: 10.1093/med/9780199331277.003.0073.
• Case 74Covey A, Pua B, Aguado A, Madoff D. Case 74. 2014, 224-226. DOI: 10.1093/med/9780199331277.003.0074.
• Case 75Covey A, Pua B, Aguado A, Madoff D. Case 75. 2014, 227-229. DOI: 10.1093/med/9780199331277.003.0075.
• Case 76Covey A, Pua B, Aguado A, Madoff D. Case 76. 2014, 230-233. DOI: 10.1093/med/9780199331277.003.0076.
• Case 77Covey A, Pua B, Aguado A, Madoff D. Case 77. 2014, 234-236. DOI: 10.1093/med/9780199331277.003.0077.
• Case 78Covey A, Pua B, Aguado A, Madoff D. Case 78. 2014, 237-239. DOI: 10.1093/med/9780199331277.003.0078.
• Case 79Covey A, Pua B, Aguado A, Madoff D. Case 79. 2014, 240-242. DOI: 10.1093/med/9780199331277.003.0079.
• Case 80Covey A, Pua B, Aguado A, Madoff D. Case 80. 2014, 243-245. DOI: 10.1093/med/9780199331277.003.0080.
• Case 81Covey A, Pua B, Aguado A, Madoff D. Case 81. 2014, 246-248. DOI: 10.1093/med/9780199331277.003.0081.
• Case 82Covey A, Pua B, Aguado A, Madoff D. Case 82. 2014, 249-251. DOI: 10.1093/med/9780199331277.003.0082.
• Case 83Covey A, Pua B, Aguado A, Madoff D. Case 83. 2014, 252-254. DOI: 10.1093/med/9780199331277.003.0083.
• Case 84Covey A, Pua B, Aguado A, Madoff D. Case 84. 2014, 255-256. DOI: 10.1093/med/9780199331277.003.0084.
• Case 85Covey A, Pua B, Aguado A, Madoff D. Case 85. 2014, 257-259. DOI: 10.1093/med/9780199331277.003.0085.
• Case 86Covey A, Pua B, Aguado A, Madoff D. Case 86. 2014, 260-262. DOI: 10.1093/med/9780199331277.003.0086.
• Case 87Covey A, Pua B, Aguado A, Madoff D. Case 87. 2014, 263-265. DOI: 10.1093/med/9780199331277.003.0087.
• Case 88Covey A, Pua B, Aguado A, Madoff D. Case 88. 2014, 266-267. DOI: 10.1093/med/9780199331277.003.0088.
• Case 89Covey A, Pua B, Aguado A, Madoff D. Case 89. 2014, 268-270. DOI: 10.1093/med/9780199331277.003.0089.
• Case 90Covey A, Pua B, Aguado A, Madoff D. Case 90. 2014, 271-273. DOI: 10.1093/med/9780199331277.003.0090.
• Case 91Covey A, Pua B, Aguado A, Madoff D. Case 91. 2014, 274-276. DOI: 10.1093/med/9780199331277.003.0091.
• Case 92Covey A, Pua B, Aguado A, Madoff D. Case 92. 2014, 277-279. DOI: 10.1093/med/9780199331277.003.0092.
• Case 93Covey A, Pua B, Aguado A, Madoff D. Case 93. 2014, 280-281. DOI: 10.1093/med/9780199331277.003.0093.
• Case 94Covey A, Pua B, Aguado A, Madoff D. Case 94. 2014, 282-284. DOI: 10.1093/med/9780199331277.003.0094.
• Case 95Covey A, Pua B, Aguado A, Madoff D. Case 95. 2014, 285-287. DOI: 10.1093/med/9780199331277.003.0095.
• Case 96Covey A, Pua B, Aguado A, Madoff D. Case 96. 2014, 288-290. DOI: 10.1093/med/9780199331277.003.0096.
• Case 97Covey A, Pua B, Aguado A, Madoff D. Case 97. 2014, 291-293. DOI: 10.1093/med/9780199331277.003.0097.
• Case 98Covey A, Pua B, Aguado A, Madoff D. Case 98. 2014, 294-295. DOI: 10.1093/med/9780199331277.003.0098.
• Case 99Covey A, Pua B, Aguado A, Madoff D. Case 99. 2014, 296-298. DOI: 10.1093/med/9780199331277.003.0099.
• Case 100Covey A, Pua B, Aguado A, Madoff D. Case 100. 2014, 299-301. DOI: 10.1093/med/9780199331277.003.0100.
• Case 101Covey A, Pua B, Aguado A, Madoff D. Case 101. 2014, 302-304. DOI: 10.1093/med/9780199331277.003.0101.
• Case 102Covey A, Pua B, Aguado A, Madoff D. Case 102. 2014, 305-307. DOI: 10.1093/med/9780199331277.003.0102.
• Case 103Covey A, Pua B, Aguado A, Madoff D. Case 103. 2014, 308-312. DOI: 10.1093/med/9780199331277.003.0103.
• PrefaceCovey A, Pua B, Aguado A, Madoff D. Preface. 2014, ix-x. DOI: 10.1093/med/9780199331277.002.0007.
• Index of CasesCovey A, Pua B, Aguado A, Madoff D. Index of Cases. 2014, 313-314. DOI: 10.1093/med/9780199331277.002.0222.
• Bland embolization versus chemoembolization of hepatocellular carcinoma before transplantationKluger MD, Halazun KJ, Barroso RT, Fox AN, Olsen SK, Madoff DC, Siegel AB, Weintraub JL, Sussman J, Brown RS, Cherqui D, Emond JC. Bland embolization versus chemoembolization of hepatocellular carcinoma before transplantation. Liver Transplantation 2014, 20: 536-543. PMID: 24493271, PMCID: PMC4095977, DOI: 10.1002/lt.23846.
• Interventional Radiology Management of Unresectable Intrahepatic CholangiocarcinomaTalenfeld A, Holzwanger D, Madoff D. Interventional Radiology Management of Unresectable Intrahepatic Cholangiocarcinoma. 2014, 201-223. DOI: 10.1007/978-3-642-40558-7_13.
• The Combination Of Palbociclib Plus Bortezomib Is Safe and Active In Patients With Previously Treated Mantle Cell Lymphoma: Final Results Of a Phase I TrialMartin P, DiLiberto M, Mason C, Ely S, Ruan J, Furman R, Chiron D, Huang X, Madoff D, Navi J, Lewis J, Bender A, Rodriguez A, Greenberg J, Coleman M, Chen-Kiang S, Leonard J. The Combination Of Palbociclib Plus Bortezomib Is Safe and Active In Patients With Previously Treated Mantle Cell Lymphoma: Final Results Of a Phase I Trial. Blood 2013, 122: 4393-4393. DOI: 10.1182/blood.v122.21.4393.4393.
• Evaluation of liver fibrosis and hepatic venous pressure gradient with MR elastography in a novel swine model of cirrhosisHuang SY, Abdelsalam ME, Harmoush S, Ensor JE, Chetta JA, Hwang KP, Stafford RJ, Madoff DC, Avritscher R. Evaluation of liver fibrosis and hepatic venous pressure gradient with MR elastography in a novel swine model of cirrhosis. Journal Of Magnetic Resonance Imaging 2013, 39: 590-597. PMID: 24532376, DOI: 10.1002/jmri.24189.
• Percutaneous Intraportal Application of Adipose Tissue–derived Mesenchymal Stem Cells Using a Balloon Occlusion Catheter in a Porcine Model of Liver FibrosisAvritscher R, Abdelsalam ME, Javadi S, Ensor J, Wallace MJ, Alt E, Madoff DC, Vykoukal JV. Percutaneous Intraportal Application of Adipose Tissue–derived Mesenchymal Stem Cells Using a Balloon Occlusion Catheter in a Porcine Model of Liver Fibrosis. Journal Of Vascular And Interventional Radiology 2013, 24: 1871-1878. PMID: 24144538, DOI: 10.1016/j.jvir.2013.08.022.
• Nodes and Soft Tissue Masses Involving the Retroperitoneum, Mesentery, Omentum, and Peritoneal LigamentsShaw C, Odisio B, Avritscher R, Madoff D. Nodes and Soft Tissue Masses Involving the Retroperitoneum, Mesentery, Omentum, and Peritoneal Ligaments. 2013, 267-279. DOI: 10.1007/978-1-4614-8217-8_19.
• Interventional Radiology in the Multidisciplinary Management of Liver Lesions: Pre- and Postoperative RolesWard T, Madoff D, Weintraub J. Interventional Radiology in the Multidisciplinary Management of Liver Lesions: Pre- and Postoperative Roles. Seminars In Liver Disease 2013, 33: 213-225. PMID: 23943102, DOI: 10.1055/s-0033-1351778.
• Characterization of in vivo ablation cavities following percutaneous microwave ablation of the liverWinokur R, Pua B, Talenfeld A, Madoff D. Characterization of in vivo ablation cavities following percutaneous microwave ablation of the liver. Journal Of Vascular And Interventional Radiology 2013, 24: s45. DOI: 10.1016/j.jvir.2013.01.101.
• Future improvements in the role of PET-CT in the assessment of hepatocellular carcinoma, prior to and following the selective internal radiation therapy (SIRT) of Yttrium-90 (Y-90)Chheang S, Tarlington L, Osborne J, Deh K, Madoff D. Future improvements in the role of PET-CT in the assessment of hepatocellular carcinoma, prior to and following the selective internal radiation therapy (SIRT) of Yttrium-90 (Y-90). Journal Of Vascular And Interventional Radiology 2013, 24: s167. DOI: 10.1016/j.jvir.2013.01.422.
• Update on Portal Vein Embolization: Evidence‐based Outcomes, Controversies, and Novel StrategiesMay BJ, Talenfeld AD, Madoff DC. Update on Portal Vein Embolization: Evidence‐based Outcomes, Controversies, and Novel Strategies. Journal Of Vascular And Interventional Radiology 2013, 24: 241-254. PMID: 23369559, DOI: 10.1016/j.jvir.2012.10.017.
• Percutaneous Portal Vein Access and Transhepatic Tract HemostasisSaad W, Madoff D. Percutaneous Portal Vein Access and Transhepatic Tract Hemostasis. Seminars In Interventional Radiology 2012, 29: 071-080. PMID: 23729976, PMCID: PMC3444873, DOI: 10.1055/s-0032-1312567.
• Portal Vein Embolization: Rationale, Technique, and Current ApplicationMay B, Madoff D. Portal Vein Embolization: Rationale, Technique, and Current Application. Seminars In Interventional Radiology 2012, 29: 081-089. PMID: 23729977, PMCID: PMC3444878, DOI: 10.1055/s-0032-1312568.
• Abstract No. 455: Current techniques for TIPS reduction in patients with refractory hepatic encephalopathyTalenfeld A, Trost D, Schiffman M, Pua B, Sista A, Madoff D. Abstract No. 455: Current techniques for TIPS reduction in patients with refractory hepatic encephalopathy. Journal Of Vascular And Interventional Radiology 2012, 23: s179. DOI: 10.1016/j.jvir.2012.01.052.
• Chapter 93B Preoperative portal vein embolization TechniqueMadoff D. Chapter 93B Preoperative portal vein embolization Technique. 2012, 1577-1586.e1. DOI: 10.1016/b978-1-4377-1454-8.00138-7.
• Tools for monitoring patients with hepatocellular carcinoma on the waiting list and after liver transplantationKneteman N, Livraghi T, Madoff D, de Santibañez E, Kew M. Tools for monitoring patients with hepatocellular carcinoma on the waiting list and after liver transplantation. Liver Transplantation 2011, 17: s117-s127. PMID: 21584926, DOI: 10.1002/lt.22334.
• Development of a Large Animal Model of Cirrhosis and Portal Hypertension Using Hepatic Transarterial Embolization: A Study in SwineAvritscher R, Wright K, Javadi S, Uthamanthil R, Gupta S, Gagea M, Bassett R, Murthy R, Wallace M, Madoff D. Development of a Large Animal Model of Cirrhosis and Portal Hypertension Using Hepatic Transarterial Embolization: A Study in Swine. Journal Of Vascular And Interventional Radiology 2011, 22: 1329-1334. DOI: 10.1016/j.jvir.2011.04.016.x.
• Development of a Large Animal Model of Cirrhosis and Portal Hypertension Using Hepatic Transarterial Embolization: A Study in SwineAvritscher R, Wright KC, Javadi S, Uthamanthil R, Gupta S, Gagea M, Bassett RL, Murthy R, Wallace MJ, Madoff DC. Development of a Large Animal Model of Cirrhosis and Portal Hypertension Using Hepatic Transarterial Embolization: A Study in Swine. Journal Of Vascular And Interventional Radiology 2011, 22: 1329-1334. PMID: 21802316, DOI: 10.1016/j.jvir.2011.04.016.
• Embolic Materials Used for Portal Vein EmbolizationThornton R, Covey A, Madoff D. Embolic Materials Used for Portal Vein Embolization. 2011, 129-136. DOI: 10.1007/978-1-84882-122-4_14.
• The Ipsilateral Approach for Right PVE with or Without Segment 4Madoff D. The Ipsilateral Approach for Right PVE with or Without Segment 4. 2011, 151-158. DOI: 10.1007/978-1-84882-122-4_17.
• Complications of Portal Vein EmbolizationKodama Y, Shaw C, Madoff D. Complications of Portal Vein Embolization. 2011, 159-168. DOI: 10.1007/978-1-84882-122-4_18.
• Indications and Contraindications for Portal Vein EmbolizationMadoff D, Vauthey J. Indications and Contraindications for Portal Vein Embolization. 2011, 123-128. DOI: 10.1007/978-1-84882-122-4_13.
• Phase I Trial of Hepatic Arterial Infusion of Nanoparticle Albumin–Bound Paclitaxel: Toxicity, Pharmacokinetics, and ActivityFu S, Naing A, Moulder SL, Culotta KS, Madoff DC, Ng CS, Madden TL, Falchook GS, Hong DS, Kurzrock R. Phase I Trial of Hepatic Arterial Infusion of Nanoparticle Albumin–Bound Paclitaxel: Toxicity, Pharmacokinetics, and Activity. Molecular Cancer Therapeutics 2011, 10: 1300-1307. PMID: 21571911, DOI: 10.1158/1535-7163.mct-11-0259.
• Abstract No. 210: Yttrium-90 resin hepatic arterial radioembolotherapy as a therapeutic adjunct to sorafenib for advanced non-transplantable, non-resectable hepatocellular cancerMahvash A, Murthy R, Avritscher R, Madoff D, Kaseb A. Abstract No. 210: Yttrium-90 resin hepatic arterial radioembolotherapy as a therapeutic adjunct to sorafenib for advanced non-transplantable, non-resectable hepatocellular cancer. Journal Of Vascular And Interventional Radiology 2011, 22: s90-s91. DOI: 10.1016/j.jvir.2011.01.231.
• High Survival Rate After Two-Stage Resection of Advanced Colorectal Liver Metastases: Response-Based Selection and Complete Resection Define OutcomeBrouquet A, Abdalla EK, Kopetz S, Garrett CR, Overman MJ, Eng C, Andreou A, Loyer EM, Madoff DC, Curley SA, Vauthey JN. High Survival Rate After Two-Stage Resection of Advanced Colorectal Liver Metastases: Response-Based Selection and Complete Resection Define Outcome. Journal Of Clinical Oncology 2011, 29: 1083-1090. PMID: 21263087, PMCID: PMC3068054, DOI: 10.1200/jco.2010.32.6132.
• Response, Survival, and Prognostic Factors After Hepatic Arterial Chemoembolization in Patients With Liver Metastases From Cutaneous MelanomaAhrar J, Gupta S, Ensor J, Ahrar K, Madoff DC, Wallace MJ, Murthy R, Tam A, Hwu P, Bedikian AY. Response, Survival, and Prognostic Factors After Hepatic Arterial Chemoembolization in Patients With Liver Metastases From Cutaneous Melanoma. Cancer Investigation 2010, 29: 49-55. PMID: 21166498, DOI: 10.3109/07357907.2010.535052.
• Exploratory Study of Hepatic Arterial Infusion Oxaliplatin With Systemic 5-Fluorouracil/Bevacizumab in Patients With Refractory Solid Tumor and Extensive Liver MetastasesCamacho LH, Garcia S, Panchal AM, Lim J, Hong DS, Ng C, Madoff DC, Fu S, Gayed I, Kurzrock R. Exploratory Study of Hepatic Arterial Infusion Oxaliplatin With Systemic 5-Fluorouracil/Bevacizumab in Patients With Refractory Solid Tumor and Extensive Liver Metastases. Clinical Colorectal Cancer 2010, 9: 311-314. PMID: 21208846, PMCID: PMC3088086, DOI: 10.3816/ccc.2010.n.045.
• Hepatic Artery Chemoembolization in Patients With Ocular Melanoma Metastatic to the LiverGupta S, Bedikian AY, Ahrar J, Ensor J, Ahrar K, Madoff DC, Wallace MJ, Murthy R, Tam A, Hwu P. Hepatic Artery Chemoembolization in Patients With Ocular Melanoma Metastatic to the Liver. American Journal Of Clinical Oncology 2010, 33: 474-480. PMID: 19935383, DOI: 10.1097/coc.0b013e3181b4b065.
• Portal Vein Embolization Prior to ResectionMadoff D, Avritscher R. Portal Vein Embolization Prior to Resection. 2010, 153-183. DOI: 10.1007/978-1-60327-522-4_11.
• A phase I study of hepatic arterial infusion of nab-paclitaxel in patients with predominant hepatic metastases.Fu S, Naing A, Moulder S, Falchook G, Culotta K, Zhang Y, Madoff D, Ng C, Lim J, Kurzrock R. A phase I study of hepatic arterial infusion of nab-paclitaxel in patients with predominant hepatic metastases. Journal Of Clinical Oncology 2010, 28: e13044-e13044. DOI: 10.1200/jco.2010.28.15_suppl.e13044.
• Abstract No. 197: Development of a large animal model for liver cirrhosisAvritscher R, Wright K, Gagea-Iurascu M, Murthy R, Madoff D. Abstract No. 197: Development of a large animal model for liver cirrhosis. Journal Of Vascular And Interventional Radiology 2010, 21: s76. DOI: 10.1016/j.jvir.2009.12.358.
• Hepatic Arterial Embolization and Chemoembolization for Imatinib-Resistant Gastrointestinal Stromal TumorsKobayashi K, Szklaruk J, Trent JC, Ensor J, Ahrar K, Wallace MJ, Madoff DC, Murthy R, Hicks ME, Gupta S. Hepatic Arterial Embolization and Chemoembolization for Imatinib-Resistant Gastrointestinal Stromal Tumors. American Journal Of Clinical Oncology 2009, 32: 574-581. PMID: 19636238, DOI: 10.1097/coc.0b013e31819cca35.
• Multiple hepatic artery aneurysms in a patient with systemic lupus erythematosusPollono E, Madoff D, Spence S, Suarez-Almazor M. Multiple hepatic artery aneurysms in a patient with systemic lupus erythematosus. Lupus 2009, 19: 93-95. PMID: 19884215, DOI: 10.1177/0961203309345721.
• Three Hundred and One Consecutive Extended Right HepatectomiesKishi Y, Abdalla EK, Chun YS, Zorzi D, Madoff DC, Wallace MJ, Curley SA, Vauthey JN. Three Hundred and One Consecutive Extended Right Hepatectomies. Annals Of Surgery 2009, 127: 171-179. PMID: 19730239, DOI: 10.1097/sla.0b013e3181b674df.
• Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: Perioperative outcome and survivalPalavecino M, Chun YS, Madoff DC, Zorzi D, Kishi Y, Kaseb AO, Curley SA, Abdalla EK, Vauthey JN. Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: Perioperative outcome and survival. Surgery 2009, 145: 399-405. PMID: 19303988, DOI: 10.1016/j.surg.2008.10.009.
• Outcomes in Lymphoma Patients with Obstructive JaundiceEgwim C, Wallace M, Wang M, Lee J, Madoff D, Ross W. Outcomes in Lymphoma Patients with Obstructive Jaundice. Gastrointestinal Endoscopy 2009, 69: ab149. DOI: 10.1016/j.gie.2009.03.235.
• Abstract No. 162: Extrahepatic Progression of Hepatic-Only Metastatic Colorectal Cancer: Impact on Combinatorial (Systemic + Local) Therapy Clinical Trial DesignMutha P, Madoff D, Mahvash A, Avritscher R, Murthy R. Abstract No. 162: Extrahepatic Progression of Hepatic-Only Metastatic Colorectal Cancer: Impact on Combinatorial (Systemic + Local) Therapy Clinical Trial Design. Journal Of Vascular And Interventional Radiology 2009, 20: s63. DOI: 10.1016/j.jvir.2008.12.149.
• Abstract No. 105: Integration of Online Reporting System for Interventional Radiology Procedure-Related Complications with the Digital Dictation System: Early ExperienceGupta S, Patel J, Wallace M, Ahrar K, Madoff D, Murthy R, Suitor C, McEnery K, Hicks M. Abstract No. 105: Integration of Online Reporting System for Interventional Radiology Procedure-Related Complications with the Digital Dictation System: Early Experience. Journal Of Vascular And Interventional Radiology 2009, 20: s41-s42. DOI: 10.1016/j.jvir.2008.12.086.
• Preoperative Portal Vein EmbolizationMadoff D. Preoperative Portal Vein Embolization. 2008, 316-334. DOI: 10.1017/cbo9780511722226.029.
• Is embolization of segment 4 portal veins before extended right hepatectomy justified?Kishi Y, Madoff DC, Abdalla EK, Palavecino M, Ribero D, Chun YS, Vauthey JN. Is embolization of segment 4 portal veins before extended right hepatectomy justified? Surgery 2008, 144: 744-751. PMID: 19081016, PMCID: PMC5901738, DOI: 10.1016/j.surg.2008.05.015.
• Le degré d’hypertrophie hépatique obtenu après embolisation portale pré-opératoire permet de prédire les résultats opératoires des hépatectomies majeures Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcomeBr J Surg94200713861394Ribero D, Abdalla E, Madoff D, Donadon M, Loyer E, Vauthey J. Le degré d’hypertrophie hépatique obtenu après embolisation portale pré-opératoire permet de prédire les résultats opératoires des hépatectomies majeures Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcomeBr J Surg94200713861394. Journal De Chirurgie Viscérale 2008, 145: 401. DOI: 10.1016/s0021-7697(08)74333-3.
• Chemotherapy With Bevacizumab Does Not Affect Liver Regeneration After Portal Vein Embolization in the Treatment of Colorectal Liver MetastasesZorzi D, Chun YS, Madoff DC, Abdalla EK, Vauthey JN. Chemotherapy With Bevacizumab Does Not Affect Liver Regeneration After Portal Vein Embolization in the Treatment of Colorectal Liver Metastases. Annals Of Surgical Oncology 2008, 15: 2765. PMID: 18636296, PMCID: PMC5901734, DOI: 10.1245/s10434-008-0035-7.
• A phase I study of hepatic arterial infusion of oxaliplatin plus intravenous fluorouracil, leucovorin, and bevacizumab in patients with predominant hepatic metastasesFu S, Chintala L, Madoff D, Hong D, Naing A, Moulder S, Wheler J, Ng C, Lim J, Patterson M, Kurzrock R. A phase I study of hepatic arterial infusion of oxaliplatin plus intravenous fluorouracil, leucovorin, and bevacizumab in patients with predominant hepatic metastases. Journal Of Clinical Oncology 2008, 26: 2534-2534. DOI: 10.1200/jco.2008.26.15_suppl.2534.
• Yttrium-90 Microsphere Radioembolotherapy of Hepatic Metastatic Neuroendocrine Carcinomas after Hepatic Arterial EmbolizationMurthy R, Kamat P, Nunez R, Madoff DC, Gupta S, Salem R, Yao JC. Yttrium-90 Microsphere Radioembolotherapy of Hepatic Metastatic Neuroendocrine Carcinomas after Hepatic Arterial Embolization. Journal Of Vascular And Interventional Radiology 2008, 19: 145-151. PMID: 18192482, DOI: 10.1016/j.jvir.2007.09.006.
• Hepatic Yttrium-90 Radioembolotherapy in Metastatic Colorectal Cancer Treated with Cetuximab or BevacizumabMurthy R, Eng C, Krishnan S, Madoff DC, Habbu A, Canet S, Hicks ME. Hepatic Yttrium-90 Radioembolotherapy in Metastatic Colorectal Cancer Treated with Cetuximab or Bevacizumab. Journal Of Vascular And Interventional Radiology 2007, 18: 1588-1591. PMID: 18057297, DOI: 10.1016/j.jvir.2007.08.015.
• Hepatic Arterial Embolization and Chemoembolization in the Management of Patients with Large-Volume Liver MetastasesKamat PP, Gupta S, Ensor JE, Murthy R, Ahrar K, Madoff DC, Wallace MJ, Hicks ME. Hepatic Arterial Embolization and Chemoembolization in the Management of Patients with Large-Volume Liver Metastases. CardioVascular And Interventional Radiology 2007, 31: 299-307. PMID: 17922160, DOI: 10.1007/s00270-007-9186-3.
• Systemic Chemotherapy and Two-Stage Hepatectomy for Extensive Bilateral Colorectal Liver Metastases: Perioperative Safety and SurvivalChun YS, Vauthey JN, Ribero D, Donadon M, Mullen JT, Eng C, Madoff DC, Chang DZ, Ho L, Kopetz S, Wei SH, Curley SA, Abdalla EK. Systemic Chemotherapy and Two-Stage Hepatectomy for Extensive Bilateral Colorectal Liver Metastases: Perioperative Safety and Survival. Journal Of Gastrointestinal Surgery 2007, 11: 1498-1505. PMID: 17849166, DOI: 10.1007/s11605-007-0272-2.
• Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcomeRibero D, Abdalla EK, Madoff DC, Donadon M, Loyer EM, Vauthey J. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. British Journal Of Surgery 2007, 94: 1386-1394. PMID: 17583900, DOI: 10.1002/bjs.5836.
• Pilot study of regional, hepatic intra‐arterial paclitaxel in patients with breast carcinoma metastatic to the liverCamacho LH, Kurzrock R, Cheung A, Barber DF, Gupta S, Madoff DC, Wallace MJ, Kim EE, Curley SA, Hortobagyi GN, Mavligit G. Pilot study of regional, hepatic intra‐arterial paclitaxel in patients with breast carcinoma metastatic to the liver. Cancer 2007, 109: 2190-2196. PMID: 17464952, DOI: 10.1002/cncr.22672.
• IntroductionMadoff D. Introduction. Techniques In Vascular And Interventional Radiology 2007, 10: 87. DOI: 10.1053/j.tvir.2007.09.006.
• IntroductionMadoff D. Introduction. Techniques In Vascular And Interventional Radiology 2007, 10: 1. DOI: 10.1053/j.tvir.2007.09.002.
• Transarterial versus Transhepatic Portal Vein Embolization to Induce Selective Hepatic Hypertrophy: A Comparative Study in SwineMadoff DC, Gupta S, Pillsbury EP, Kan Z, Tinkey PT, Stephens LC, Ensor JE, Hicks ME, Wright KC. Transarterial versus Transhepatic Portal Vein Embolization to Induce Selective Hepatic Hypertrophy: A Comparative Study in Swine. Journal Of Vascular And Interventional Radiology 2007, 18: 79-93. PMID: 17296708, DOI: 10.1016/j.jvir.2006.10.018.
• Chapter 84 Portal Vein EmbolizationIMAMURA H, TAKAYAMA T, MAKUUCHI M, VAUTHEY J, MADOFF D, ABDALLA E. Chapter 84 Portal Vein Embolization. 2007, 1452-1471. DOI: 10.1016/b978-1-4160-3256-4.50103-4.
• Hepatic artery chemoembolization for 110 gastrointestinal stromal tumorsKobayashi K, Gupta S, Trent JC, Vauthey J, Krishnamurthy S, Ensor J, Ahrar K, Wallace MJ, Madoff DC, Murthy R, McRae SE, Hicks ME. Hepatic artery chemoembolization for 110 gastrointestinal stromal tumors. Cancer 2006, 107: 2833-2841. PMID: 17096432, DOI: 10.1002/cncr.22336.
• Portal Vein Embolization: A Preoperative Approach to Improve the Safety of Major Hepatic ResectionMadoff D, Abdalla E, Wallace M, Ng C, Ribero D, Vauthey J. Portal Vein Embolization: A Preoperative Approach to Improve the Safety of Major Hepatic Resection. Current Medical Imaging Formerly Current Medical Imaging Reviews 2006, 2: 385-404. DOI: 10.2174/157340506778777150.
• Update on the Management of Neuroendocrine Hepatic MetastasesMadoff DC, Gupta S, Ahrar K, Murthy R, Yao JC. Update on the Management of Neuroendocrine Hepatic Metastases. Journal Of Vascular And Interventional Radiology 2006, 17: 1235-1250. PMID: 16923972, DOI: 10.1097/01.rvi.0000232177.57950.71.
• Pilot study of regional hepatic intra-arterial (HIA) paclitaxel in patients (Pts) with breast carcinoma metastatic to the liverMavligit G, Kurzrock R, Cheung A, Gupta S, Madoff D, Wallace M, Kim E, Curley S, Hortobagyi G, Camacho L. Pilot study of regional hepatic intra-arterial (HIA) paclitaxel in patients (Pts) with breast carcinoma metastatic to the liver. Journal Of Clinical Oncology 2006, 24: 10626-10626. DOI: 10.1200/jco.2006.24.18_suppl.10626.
• Yttrium-90 microsphere treatment for liver dominant hepatic metastases from lung cancerMurthy R, Oh Y, Tam A, Gupta S, Madoff D, Glisson B. Yttrium-90 microsphere treatment for liver dominant hepatic metastases from lung cancer. Journal Of Clinical Oncology 2006, 24: 17122-17122. DOI: 10.1200/jco.2006.24.18_suppl.17122.
• Percutaneous Radiofrequency Ablation of Renal Tumors: Technique, Complications and OutcomesAhrar K, Matin S, Wood C, Wallace M, Gupta S, Madoff D, Rao S, Tannir N, Jonasch E, Pisters L, Rozner M, Kennamer D, Hicks M. Percutaneous Radiofrequency Ablation of Renal Tumors: Technique, Complications and Outcomes. Investigative Urology 2006, 175: 1650. DOI: 10.1016/s0022-5347(06)00186-8.
• Embolotherapy for Organ AblationMadoff D, Verma R, Ahrar K. Embolotherapy for Organ Ablation. 2006, 201-220. DOI: 10.1007/3-540-33257-x_16.
• Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumorsGupta S, Johnson MM, Murthy R, Ahrar K, Wallace MJ, Madoff DC, McRae SE, Hicks ME, Rao S, Vauthey J, Ajani JA, Yao JC. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors. Cancer 2005, 104: 1590-1602. PMID: 16134179, DOI: 10.1002/cncr.21389.
• 2304 Radiologie interventionnelle et pathologie spleniqueDenys A, Madoff D, Bessoud B, Qanadli S, Doenz F, Schnyder P. 2304 Radiologie interventionnelle et pathologie splenique. Journal D Imagerie Diagnostique Et Interventionnelle 2005, 86: 1194. DOI: 10.1016/s0221-0363(05)74952-0.
• Yttrium 90 Resin Microspheres for the Treatment of Unresectable Colorectal Hepatic Metastases after Failure of Multiple Chemotherapy Regimens: Preliminary ResultsMurthy R, Xiong H, Nunez R, Cohen AC, Barron B, Szklaruk J, Madoff DC, Gupta S, Wallace MJ, Ahrar K, Hicks ME. Yttrium 90 Resin Microspheres for the Treatment of Unresectable Colorectal Hepatic Metastases after Failure of Multiple Chemotherapy Regimens: Preliminary Results. Journal Of Vascular And Interventional Radiology 2005, 16: 937-945. PMID: 16002501, DOI: 10.1097/01.rvi.0000161142.12822.66.
• Portal Vein Embolization in Preparation for Major Hepatic Resection: Evolution of a New Standard of CareMadoff DC, Abdalla EK, Vauthey JN. Portal Vein Embolization in Preparation for Major Hepatic Resection: Evolution of a New Standard of Care. Journal Of Vascular And Interventional Radiology 2005, 16: 779-790. PMID: 15947041, DOI: 10.1097/01.rvi.0000159543.28222.73.
• Percutaneous Radiofrequency Ablation of Renal Tumors: Technique, Complications, and OutcomesAhrar K, Matin S, Wood CG, Wallace MJ, Gupta S, Madoff DC, Rao S, Tannir NM, Jonasch E, Pisters LL, Rozner MA, Kennamer DL, Hicks ME. Percutaneous Radiofrequency Ablation of Renal Tumors: Technique, Complications, and Outcomes. Journal Of Vascular And Interventional Radiology 2005, 16: 679-688. PMID: 15872323, DOI: 10.1097/01.rvi.0000153589.10908.5f.
• Transhepatic Ipsilateral Right Portal Vein Embolization Extended to Segment IV: Improving Hypertrophy and Resection Outcomes with Spherical Particles and CoilsMadoff DC, Abdalla EK, Gupta S, Wu TT, Morris JS, Denys A, Wallace MJ, Morello FA, Ahrar K, Murthy R, Lunagomez S, Hicks ME, Vauthey JN. Transhepatic Ipsilateral Right Portal Vein Embolization Extended to Segment IV: Improving Hypertrophy and Resection Outcomes with Spherical Particles and Coils. Journal Of Vascular And Interventional Radiology 2005, 16: 215-225. PMID: 15713922, DOI: 10.1097/01.rvi.0000147067.79223.85.
• NETMadoff D. NET. Journal Of Vascular And Interventional Radiology 2005, 16: p18. DOI: 10.1016/s1051-0443(05)70031-2.
• Re: Management of TIPS-related Refractory Hepatic Encephalopathy with Reduced Wallgraft Endoprostheses: Drs. Madoff and Wallace respondMadoff D, Wallace M. Re: Management of TIPS-related Refractory Hepatic Encephalopathy with Reduced Wallgraft Endoprostheses: Drs. Madoff and Wallace respond. Journal Of Vascular And Interventional Radiology 2004, 15: 885-886. DOI: 10.1097/01.rvi.0000130371.33875.57.
• Re: Management of TIPS-related Refractory Hepatic Encephalopathy with Reduced Wallgraft Endoprostheses Drs. Madoff et al respondMadoff D, Wallace M, Skolkin M, Toombs B. Re: Management of TIPS-related Refractory Hepatic Encephalopathy with Reduced Wallgraft Endoprostheses Drs. Madoff et al respond. Journal Of Vascular And Interventional Radiology 2003, 14: 1469. DOI: 10.1016/s1051-0443(07)60298-x.
• Re: Management of TIPS-related Refractory Hepatic Encephalopathy with Reduced Wallgraft EndoprosthesesMadoff D, Wallace M, Skolkin M, Toombs B. Re: Management of TIPS-related Refractory Hepatic Encephalopathy with Reduced Wallgraft Endoprostheses. Journal Of Vascular And Interventional Radiology 2003, 14: 1469. PMID: 14605116, DOI: 10.1097/01.rvi.0000096775.74047.
• Radio-frequency tissue ablation of the liver: in vivo and ex vivo experiments with four different systemsDenys AL, Baere T, Kuoch V, Dupas B, Chevallier P, Madoff DC, Schnyder P, Doenz F. Radio-frequency tissue ablation of the liver: in vivo and ex vivo experiments with four different systems. European Radiology 2003, 13: 2346-2352. PMID: 12942277, DOI: 10.1007/s00330-003-1970-0.
• Management of TIPS-related Refractory Hepatic Encephalopathy with Reduced Wallgraft EndoprosthesesMadoff DC, Perez-Young IV, Wallace MJ, Skolkin MD, Toombs BD. Management of TIPS-related Refractory Hepatic Encephalopathy with Reduced Wallgraft Endoprostheses. Journal Of Vascular And Interventional Radiology 2003, 14: 369-374. PMID: 12631643, DOI: 10.1097/01.rvi.0000058418.01661.48.
• Portal Vein Embolization with Polyvinyl Alcohol Particles and Coils in Preparation for Major Liver Resection for Hepatobiliary Malignancy: Safety and Effectiveness—Study in 26 Patients1Madoff DC, Hicks ME, Abdalla EK, Morris JS, Vauthey JN. Portal Vein Embolization with Polyvinyl Alcohol Particles and Coils in Preparation for Major Liver Resection for Hepatobiliary Malignancy: Safety and Effectiveness—Study in 26 Patients1. Radiology 2003, 227: 251-60. PMID: 12616006, DOI: 10.1148/radiol.2271012010.
• Coexistent Rupture of the Proximal Right Subclavian and Internal Mammary Arteries after Blunt Chest TraumaMadoff D, Brathwaite C, Manzione J, Bilaniuk J, Giron F, Char D, Choi J, Bilfinger T. Coexistent Rupture of the Proximal Right Subclavian and Internal Mammary Arteries after Blunt Chest Trauma. Journal Of Trauma And Acute Care Surgery 2000, 48: 521. PMID: 10744296, DOI: 10.1097/00005373-200003000-00026.
• Catastrophic Caudad Spread of a Peritonsillar Abscess: A Case ReportManecke G, Marghoob S, Finzel K, Madoff D, Quijano I, Poppers P. Catastrophic Caudad Spread of a Peritonsillar Abscess: A Case Report. Anesthesiology 1999, 91: 1956. PMID: 10598643, DOI: 10.1097/00000542-199912000-00053.
• rCBF (015 PET) during cognitive and physiological stimulation in schizophrenicsGanguli R, Mintun M, Becker J, Brar J, Diehl D, DeLeo M, Madoff D, Martidis A. rCBF (015 PET) during cognitive and physiological stimulation in schizophrenics. Biological Psychiatry 1994, 35: 621-622. DOI: 10.1016/0006-3223(94)90683-1.
• Functional neuroanatomy of verbal free recall: A replication studyBecker J, Mintun M, Diehl D, Dobkin J, Martidis A, Madoff D, Dekosky S. Functional neuroanatomy of verbal free recall: A replication study. Human Brain Mapping 1994, 1: 284-292. PMID: 24591197, DOI: 10.1002/hbm.460010406.